https://www.endocrine.org/podcast https://www.endocrine.org/-/media/15b510a8696d4535ad45265c5911c9fb.ashx https://www.endocrine.org/podcast The Endocrine News Podcast, a free service of the Endocrine Society, features interviews with experts addressing the latest research and trends in the field of endocrinology. Let us know what you’d like to hear about in a future episode at podcast@endocrine.org. en-us Endocrine Society. Copyright 2026 Wed, 21 Jan 2026 06:00:00 EST Endocrine Society Endocrine News Podcast, a free service of the Endocrine Society, features interviews with experts addressing the latest research and trends in the field of endocrinology. Let us know what you’d like to hear about in a future episode at podcast@endocrine.org. Research and Trends in Endocrinology Endocrine Society endoit@endo-society.org No medical, endocrine, testosterone, diabetes, cancer TV-G Washington, DC Monthly Wed, 21 Jan 2026 06:00:00 EST https://www.endocrine.org/podcast/enp1-prototype-male-pill Mon, 4 Jun 2018 09:00:00 EDT We talk with Stephanie Page, a professor of medicine at the University of Washington, about research on what she calls a prototype male pill. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast. https://www.endocrine.org/-/media/322a5cb8f1af4af48d615cac255db0e9.m4a 12:55 We talk with Stephanie Page, a professor of medicine at the University of Washington, about research on what she calls a prototype male pill. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast 2018 medicine, testosterone, reproductive, male, health no https://www.endocrine.org/podcast/enp2-autoimmune-diabetes-outcomes-and-anticancer-agents Tue, 5 Jun 2018 09:00:00 EDT We talk about diabetes and cancer with Anupam Kotwal, endocrinology fellow at the Mayo Clinic. His research shows the potential for autoimmune diabetes outcomes from novel anti-cancer agents. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast. https://www.endocrine.org/-/media/b4eac5a328804d6d9dc2aad3491bef6e.m4a 23:53 We talk about diabetes and cancer with Anupam Kotwal, endocrinology fellow at the Mayo Clinic. His research shows the potential for autoimmune diabetes outcomes from novel anti-cancer agents. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast 2018 medicine, diabetes, cancer, health no https://www.endocrine.org/podcast/enp3-semen-quality-and-general-male-health Mon, 25 Jun 2018 09:00:00 EDT We talk with Alberto Ferlin, a professor of endocrinology at the University of Brescia, Italy, about his cohort findings connecting semen quality, reproductive function, and conditions in men such as hypogonadism, high body-mass index, and metabolic syndrome. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast. https://www.endocrine.org/-/media/0371caf78cb04802875227beb29339a9.m4a 18:32 We talk with Alberto Ferlin, a professor of endocrinology at the University of Brescia, Italy, about his cohort findings connecting semen quality, reproductive function, and conditions in men such as hypogonadism, high body-mass index, and metabolic syndrome. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast 2018 medicine, testosterone, reproductive, male, health no https://www.endocrine.org/podcast/enp4-preconception-counseling Thu, 8 Aug 2018 11:30:00 EDT In this episode, we speak with Angela Magdaleno, from the Lehigh Valley Health Network, about preconception counseling for women with diabetes. Dr. Magdaleno presented findings of a patient review and a survey of providers at the Endocrine Society’s annual meeting. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast. https://www.endocrine.org/-/media/ae78188acb90477eb448afe42cb4af3b.m4a 11:36 In this episode, we speak with Angela Magdaleno, from the Lehigh Valley Health Network, about preconception counseling for women with diabetes. Dr. Magdaleno presented findings of a patient review and a survey of providers at the Endocrine Society’s annual meeting. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast 2018 medicine, diabetes, reproductive, female, health, pregnancy no https://www.endocrine.org/podcast/enp5-disorders-in-childhood-cancer-survivors Wed, 5 Sep 2018 15:30:00 EDT We interview Charles Sklar, from Memorial Sloan-Kettering Cancer Center, about the latest Endocrine Society clinical practice guideline. Dr. Sklar talks about the need to screen for endocrine disorders in long-term survivors of childhood cancer. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast. https://www.endocrine.org/-/media/3982fc24f8ed4a17ad38bd5e80c42fb4.m4a 18:56 We interview Charles Sklar, from Memorial Sloan-Kettering Cancer Center, about the latest Endocrine Society clinical practice guideline. Dr. Sklar talks about the need to screen for endocrine disorders in long-term survivors of childhood cancer. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast 2018 medicine, cancer, endocrine, health no https://www.endocrine.org/podcast/enp6-new-treatment-for-perimenopause Mon, 24 Sep 2018 15:30:00 EDT As part of Women’s Health Month, we speak with Jerilynn Prior, who talks about a new treatment approach to perimenopause: oral, micronized progesterone. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast. https://www.endocrine.org/-/media/8ad431e3e249428f94cd70f1c06b606d.m4a 23:04 As part of Women’s Health Month, we speak with Jerilynn Prior, who talks about a new treatment approach to perimenopause: oral, micronized progesterone. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast 2018 medicine, perimenopause, menopause, endocrine, health no https://www.endocrine.org/podcast/enp7-nuclear-receptors-and-transcriptional-regulation Wed, 10 Oct 2018 09:15:00 EDT We talk about nuclear receptor biology with Laurel Coons, first author of an Endocrinology article on hormone-mediated enhancer activation. The Endocrine Society is a sponsor of the upcoming Great Lakes Nuclear Receptor Conference in Minneapolis and is excited to share this nuclear receptor focused interview with you. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast. https://www.endocrine.org/-/media/20287028194747cbb27209f876f3e153.m4a 26:35 We talk about nuclear receptor biology with Laurel Coons, first author of an Endocrinology article on hormone-mediated enhancer activation. The Endocrine Society is a sponsor of the upcoming Great Lakes Nuclear Receptor Conference in Minneapolis and is excited to share this nuclear receptor focused interview with you. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast 2018 medicine, endocrine, health no https://www.endocrine.org/podcast/enp8-obesity-and-breast-cancer Mon, 5 Nov 2018 16:30:00 EST We talk with Kristy Brown, assistant professor of biochemistry and medicine, and Priya Bhardwaj, a PhD candidate, both at Weill Cornell Medicine, about their research correlating obesity with DNA damage in the breast epithelium of BRCA mutation carriers, and investigating potential connections with adipose inflammation and elevated aromatase expression. They presented their research at the Endocrine Society's annual meeting in Chicago. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast. https://www.endocrine.org/-/media/35ba1d1020ef469db78fd5d3dd4d8df1.m4a 11:07 We talk with Kristy Brown, assistant professor of biochemistry and medicine, and Priya Bhardwaj, a PhD candidate, both at Weill Cornell Medicine, about their research correlating obesity with DNA damage in the breast epithelium of BRCKA mutation carriers. and investigating potential connections with adipose inflammation and elevated aromatase expression. They presented their research at the Endocrine Society's annual meeting in Chicago. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast 2018 medicine, endocrine, health, obesity no https://www.endocrine.org/podcast/enp9-questions-about-osteoporosis Wed, 28 Nov 2018 09:15:00 EST We talk with Ann E. Kearns, associate professor of medicine at the Mayo Clinic, about the questions endocrinologists are asked by their patients about osteoporosis. Dr. Kearns led a discussion about osteoporosis treatment and care in September at the Endocrine Society's Clinical Endocrinology Update in Miami. We spoke with her there. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast. https://www.endocrine.org/-/media/e1e0496564af421b8aec8630e92cb022.m4a 19:08 We talk with Ann E. Kearns, associate professor of medicine at the Mayo Clinic, about the questions endocrinologists are asked by their patients about osteoporosis. Dr. Kearns led a discussion about osteoporosis treatment and care in September at the Endocrine Society's Clinical Endocrinology Update in Miami. We spoke with her there. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast 2018 medicine, endocrine, health, osteoporosis no https://www.endocrine.org/podcast/enp10-adrenal-fatigue-debate Fri, 21 Dec 2018 10:40:00 EST We talk with James Findling from the Medical College of Wisconsin about the debate surrounding the symptoms that some see as indicative of adrenal fatigue and failure and others see as a false positive for a condition that, in fact, does not exist. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast. https://www.endocrine.org/-/media/e92679bc64804df4bf501ec3b00d779b.m4a 17:03 We talk with James Findling from the Medical College of Wisconsin about the debate surrounding the symptoms that some see as indicative of adrenal fatigue and failure and others see as a false positive for a condition that, in fact, does not exist. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast 2018 adrenal, endocrine, health, fatigue no https://www.endocrine.org/podcast/enp11-get-ready-for-endo-2019 Wed, 30 Jan 2019 10:20:00 EST R. Michael Tuttle, from Memorial Sloan Kettering and Weill Medical College, talks with Caitlin and Aaron about the upcoming ENDO 2019 and especially how first-time attendees and trainees can navigate the sometimes overwhelming experience. Also, Caitlin tells us about the upcoming Women in Endocrinology Thematic Collection. The Society is seeking nominations for this collection, which will be published in March in time for the meeting. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast. https://www.endocrine.org/-/media/b0489b508d06463f98f282530f6502dc.m4a 17:38 R. Michael Tuttle, from Memorial Sloan Kettering and Weill Medical College, talks with Caitlin and Aaron about the upcoming ENDO 2019 and especially how first-time attendees and trainees can navigate the sometimes overwhelming experience. Also, Caitlin tells us about the upcoming Women in Endocrinology Thematic Collection. The Society is seeking nominations for this collection, which will be published in March in time for the meeting. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast 2019 endocrine, meeting, health no https://www.endocrine.org/podcast/enp12-women-in-endocrinology-series-stina-rikke-jensen-and-the-intestinal-insulin-receptor Mon, 11 Mar 2019 12:20:00 EDT We celebrate women in endocrinology by launching this podcast series, talking with authors of 12 influential, high-impact research papers representing the spectrum of basic through clinical research, geographical diversity and career stage, published in Endocrine Society journals since 2017. Here we speak with Stina Rikke Jensen, PhD, a researcher at Novozymes in Denmark. Her 2017 Endocrinology paper, on biological roles of insulin and its receptor in murine intestinal growth and function, is part of a special thematic collection of these 12 influential papers. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast. https://www.endocrine.org/-/media/99a14f87584649088cce7e83959a69e7.m4a 19:34 We celebrate women in endocrinology by launching this podcast series, talking with authors of 12 influential, high-impact research papers representing the spectrum of basic through clinical research, geographical diversity and career stage, published in Endocrine Society journals since 2017. Here we speak with Stina Jensen, a researcher at Novozymes in Denmark. Her 2017 Endocrinology paper, on biological roles of insulin and its receptor in murine intestinal growth and function, is part of a special thematic collection of these 12 influential papers. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast 2019 endocrine, insulin, endocrinology no https://www.endocrine.org/podcast/enp13-insulin-affordability Mon, 18 Mar 2019 10:20:00 EDT We talk about insulin affordability with Alvin Powers, MD, from Vanderbilt University and the Endocrine Society's chief professional and clinical affairs officer, Rob Lash, MD. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast. https://www.endocrine.org/-/media/260372257c064331b23b93c8767a175d.m4a 17:40 We talk about insulin affordability with Alvin Powers, MD, from Vanderbilt University and the Endocrine Society's chief professional and clinical affairs officer, Rob Lash, MD. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast 2019 endocrine, insulin, affordability no https://www.endocrine.org/podcast/enp14-women-in-endocrinology-series-varykina-thackray-on-pcos-and-hyperandrogenism Wed, 27 Mar 2019 13:35:00 EDT We continue our special Women in Endocrinology series. Caitlin talks with Varykina Thackray, PhD, from the University of California, San Diego, about her 2018 article in JCEM about polycystic ovary syndrome and hyperandrogenism. This paper was selected for a special thematic collection of Endocrine Society-published articles by women. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast. https://www.endocrine.org/-/media/b11ab2baca3b407db77e2611580c41e0.m4a 25:53 We continue our special Women in Endocrinology series. Caitlin talks with Varykina Thackray, PhD, from the University of California, San Diego, about her 2018 article in JCEM about polycystic ovary syndrome and hyperandrogenism. This paper was selected for a special thematic collection of Endocrine Society-published articles by women. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast 2019 endocrine, PCOS no https://www.endocrine.org/podcast/enp15-anuja-dokras-on-pcos-race-and-anxiety Wed, 27 Mar 2019 13:45:00 EDT Aaron catches up with Anuja Dokras MD, PhD, a physician at the Hospital of the University of Pennsylvania and director of the Penn Polycystic Ovary Syndrome Center, about her presentation at ENDO 2019 on anxiety, depression, and quality of life between white and black women with polycystic ovary syndrome. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast. https://www.endocrine.org/-/media/ad1e678bddc2409cbb27000210e913e9.m4a 9:04 Aaron catches up with Anuja Dokras MD, PhD, a physician at the Hospital of the University of Pennsylvania and director of the Penn Polycystic Ovary Syndrome Center, about her presentation at ENDO 2019 on anxiety, depression, and quality of life between white and black women with polycystic ovary syndrome. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast 2019 endocrine, PCOS no https://www.endocrine.org/podcast/enp16-women-in-endocrinology-series-rebecca-simmons-on-islet-dysfunction-in-igr Mon, 8 Apr 2019 09:21:00 EDT We continue our special Women in Endocrinology series. Caitlin talks with Rebecca Simmons, MD, from the Children’s Hospital of Philadelphia, about her 2018 article in Endocrinology about islet dysfunction in intrauterine growth restriction. This paper was selected for a special thematic collection of Endocrine Society-published articles by women. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast. https://www.endocrine.org/-/media/1222071489ab4e68942370f4063af76c.m4a 13:28 We continue our special Women in Endocrinology series. Caitlin talks with Rebecca Simmons, MD, from the Children’s Hospital of Philadelphia, about her 2018 article in Endocrinology about islet dysfunction in intrauterine growth restriction. This paper was selected for a special thematic collection of Endocrine Society-published articles by women. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast 2019 endocrine, pregnancy no https://www.endocrine.org/podcast/enp17-bouncing-back Mon, 29 Apr 2019 10:21:00 EDT There are good days and bad days. For the endocrinologist, that bad day can happen when a grant application or journal submission is rejected or following a misstep with a patient or in the lab. In this episode, Aaron and guest host Cecilia Low Wang, MD, from the University of Colorado School of Medicine, talk about how young researchers and trainees can understand, learn from, and bounce back from rejection and other challenges when building a career in clinical practice or scientific research. Our guests are Joy Wu, MD, PhD, from Stanford University and Rob Fowkes, PhD, from the Royal Veterinary College at the University of London. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast. https://www.endocrine.org/-/media/b7b346663dfd4789a8a5933ad74418c4.m4a 20:23 There are good days and bad days. For the endocrinologist, that bad day can happen when a grant application or journal submission is rejected or following a misstep with a patient or in the lab. In this episode, Aaron and guest host Cecilia Low Wang, MD, from the University of Colorado School of Medicine, talk about how young researchers and trainees can understand, learn from, and bounce back from rejection and other challenges when building a career in clinical practice or scientific research. Our guests are Joy Wu, MD, PhD, from Stanford University and Rob Fowkes, PhD, from the Royal Veterinary College at the University of London. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast 2019 endocrine, research, training, career no https://www.endocrine.org/podcast/enp18-hypoglycemia-and-older-adults-with-t1d Thu, 9 May 2019 10:36:00 EDT Caitlin and Aaron talk with Dr. Anders Carlson, medical director of the International Diabetes Center in Minneapolis, about his research on hypoglycemia in older adults with type 1 diabetes. Dr. Carlson presented this research at the Endocrine Society’s 2019 annual meeting in New Orleans. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast. https://www.endocrine.org/-/media/5c8ced6d3d9344a084a84c2238080ccf.m4a 11:03 Caitlin and Aaron talk with Dr. Anders Carlson, medical director of the International Diabetes Center in Minneapolis, about his research on hypoglycemia in older adults with type 1 diabetes. Dr. Carlson presented this research at the Endocrine Society’s 2019 annual meeting in New Orleans. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast 2019 endocrine, hypoglycemia, diabetes no https://www.endocrine.org/podcast/enp19-bpa-and-circadian-rhythms Mon, 20 May 2019 10:01:00 EDT Aaron talks with Deborah Kurrasch, PhD, associate professor at the University of Calgary, and Dinu Nesan, PhD, postdoctoral fellow also at University of Calgary. At the Endocrine Society's annual meeting in 2019, they presented research on BPA exposure's effects on circadian rhythms in mice during pregnancy. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast. https://www.endocrine.org/-/media/2149e8bea9a4407698a84a3953699fb4.m4a 11:14 Aaron talks with Deborah Kurrasch, PhD, associate professor at the University of Calgary, and Dinu Nesan, PhD, postdoctoral fellow also at University of Calgary. At the Endocrine Society's annual meeting in 2019, they presented research on BPA exposure's effects on circadian rhythms in mice during pregnancy. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast 2019 endocrine, BPA, EDC no https://www.endocrine.org/podcast/enp20-burosumab Wed, 29 May 2019 10:11:00 EDT We look into promising findings from clinical trials regarding Burosumab, a human monoclonal antibody designed for the treatment of X-linked hypophosphatemia. With us are Erik Imel, MD from the Indiana University School of Medicine and Suzanne Marie Jan De Beur, MD from Johns Hopkins University School of Medicine. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast. https://www.endocrine.org/-/media/f92b1f6e17854eadbd8d2fca91493335.m4a 18:45 We look into promising findings from clinical trials regarding Burosumab, a human monoclonal antibody designed for the treatment of X-linked hypophosphatemia. With us are Erik Imel, MD from the Indiana University School of Medicine and Suzanne Marie Jan De Beur, MD from Johns Hopkins University School of Medicine. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast 2019 endocrine, phosphate, hypophosphatemia no https://www.endocrine.org/podcast/enp21-getting-published Fri, 14 June 2019 10:04:00 EDT Getting published can be a challenging journey. In this episode, Caitlin and Aaron talk with Andrea Gore, Ph.D., from the University of Texas at Austin. Dr. Gore has published more than 150 articles and is a past Editor-in-Chief of the journal Endocrinology. Here she talks about what makes for a well-written scientific paper and about the peer review process: what to expect and how to understand the feedback from editors. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast. https://www.endocrine.org/-/media/8792c89006bf4554afc7b916e7416f4b.m4a 18:54 Getting published can be a challenging journey. In this episode, Caitlin and Aaron talk with Andrea Gore, Ph.D., from the University of Texas at Austin. Dr. Gore has published more than 150 articles and is a past Editor-in-Chief of the journal Endocrinology. Here she talks about what makes for a well-written scientific paper and about the peer review process: what to expect and how to understand the feedback from editors. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast 2019 endocrine, research, publishing no https://www.endocrine.org/podcast/enp22-neonatal-vitamin-d-deficiency-and-insulin Tue, 2 July 2019 16:15:00 EDT Caitlin and Aaron talk with Kyle McNerney, MD, from Washington University in St. Louis School of Medicine. At ENDO 2019, Dr. McNerney presented a study to determine the connection between vitamin D deficiency in pregnancy and insulin resistance in children. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast. https://www.endocrine.org/-/media/868e1d305e184a8b8bf146c01768d249.m4a 9:51 Caitlin and Aaron talk with Kyle McNerney, MD, from Washington University in St. Louis School of Medicine. At ENDO 2019, Dr. McNerney presented a study to determine the connection between vitamin D deficiency in pregnancy and insulin resistance in children. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast 2019 endocrine, vitamin d, pregnancy, insulin no https://www.endocrine.org/podcast/enp23-edcs-and-the-eu Mon, 5 August 2019 10:46:00 EDT Caitlin talks about the European Union’s recent resolution on endocrine-disrupting chemicals. She is joined by Rémy Slama, PhD, an environmental epidemiologist and senior investigator at INSERM, France’s National Institute of Health and Medical Research, and Barbara Demeneix, PhD, professor in the Comparative Physiology Laboratory within the Natural History Museum in Paris. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast. https://www.endocrine.org/-/media/9dd29d2db7364a5c9edf2c3786f16f7c.m4a 35:01 Caitlin talks about the European Union’s recent resolution on endocrine-disrupting chemicals. She is joined by Rémy Slama, PhD, an environmental epidemiologist and senior investigator at INSERM, France’s National Institute of Health and Medical Research, and Barbara Demeneix, PhD, professor in the Comparative Physiology Laboratory within the Natural History Museum in Paris. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast 2019 endocrine, edc, eu no https://www.endocrine.org/podcast/enp24-prototype-male-pill-update Tue, 20 August 2019 10:16:00 EDT A year after we interviewed her at ENDO 2018, we talk again with Stephanie Page, MD, PhD, from University of Washington, about her continuing research on a prototype male pill. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast. https://www.endocrine.org/-/media/b11593e63f28488888ac57195248f387.m4a 19:45 A year after we interviewed her at ENDO 2018, we talk again with Stephanie Page, MD, PhD, from University of Washington, about her continuing research on a prototype male pill. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast 2019 endocrine, reproduction, male no https://www.endocrine.org/podcast/enp25-time-restricted-eating-and-preventing-breast-cancer Tue, 10 September 2019 13:12:00 EDT Aaron speaks with Manasi Das, PhD, of the University of California San Diego. At ENDO 2019 in New Orleans, Dr. Das presented research on post-menopausal obesity, suggesting that time restricted feeding can delay breast cancer in a mouse model. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast. https://www.endocrine.org/-/media/212af298076e4cb1ba7d39280a7fc4d0.m4a 12:15 Aaron speaks with Manasi Das, PhD, of the University of California San Diego. At ENDO 2019 in New Orleans, Dr. Das presented research on post-menopausal obesity, suggesting that time restricted feeding can delay breast cancer in a mouse model. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast 2019 endocrine, breast cancer, cancer, obesity, menopause no https://www.endocrine.org/podcast/enp26-treating-symptoms-of-menopause Thu, 17 October 2019 15:55:00 EDT We talk about the sometimes conflicting perspectives in the treatment of menopausal symptoms with Cynthia Stuenkel, M.D., clinical professor of medicine at the University of California, San Diego, School of Medicine. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast. https://www.endocrine.org/-/media/6649ef5b723e4669bf3f0f220c6be113.m4a 38:50 We talk about the sometimes conflicting perspective in the treatment of menopausal symptoms with Cynthia Stuenkel, M.D., clinical professor of medicine at the University of California, San Diego, School of Medicine. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast 2019 endocrine, menopause no https://www.endocrine.org/podcast/enp27-treating-cushings-disease Mon, 4 November 2019 10:05:00 EST Aaron talks about treating Cushing's disease with Maria Fleseriu, MD, professor of medicine and neurological surgery at Oregon Health and Science University. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast. https://www.endocrine.org/-/media/d945d096cee5446d9c351c1f5efb8a04.m4a 22:47 Aaron talks about treating Cushing's disease with Maria Fleseriu, MD, professor of medicine and neurological surgery at Oregon Health and Science University. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast 2019 endocrine, Cushings, pituitary, cortisol no https://www.endocrine.org/podcast/enp28-kisspeptin-and-estradiol-induced-prolactin-surge Mon, 26 November 2019 12:45:00 EST Caitlin talks with author and researcher Nayara Aquino, PhD, from the Federal University of Minas Gerais, Brazil, about her research on neuroendocrine control of the female reproductive system. Her paper, published in Endocrinology in June 2017, was selected for the Endocrine Society’s Women in Endocrinology Thematic Issue. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast. https://www.endocrine.org/-/media/df5285fd2e4040ec81168de422ffe957.m4a 16:53 Caitlin talks with author and researcher Nayara Aquino, PhD, from the Federal University of Minas Gerais, Brazil, about her research on neuroendocrine control of the female reproductive system. Her paper, published in Endocrinology in June 2017, was selected for the Endocrine Society’s Women in Endocrinology Thematic Issue. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast 2019 endocrine, kisspeptin, estradiol, prolactin no https://www.endocrine.org/podcast/enp29-postdoc-to-faculty Tue, 17 December 2019 12:29:00 EST Aaron talks about finding your path after your postdoc with W. Lee Kraus, PhD, from the University of Texas Southwestern Medical Center and Nicola Partridge, PhD, from New York University College of Dentistry. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast. https://www.endocrine.org/-/media/dd68b24f8133407f9302a312815d617b.m4a 23:11 Aaron talks about finding your path after your postdoc with W. Lee Kraus, PhD, from the University of Texas Southwestern Medical Center and Nicola Partridge, PhD, from New York University College of Dentistry. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast 2019 endocrine, education, training no https://www.endocrine.org/podcast/enp30-acromegaly Tue, 28 January 2020 12:00:00 EST Aaron welcomes back Maria Fleseriu, MD, from Oregon Health and Science University, this time to talk about the latest in acromegaly research and treatment. He also speaks with Marvin Avila, an acromegaly patient living in the Washington, DC, metro area. Endocrine Society members, for a chance to win a pituitary pin, please complete a survey at https://education.endocrine.org/acromegalypodcast (login required). This episode is supported by Pfizer through an unrestricted, educational grant. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast. https://www.endocrine.org/-/media/08cc27f98cf04109a454137c9a8f3500.m4a 26:33 Aaron welcomes back Maria Fleseriu, MD, from Oregon Health and Science University, this time to talk about the latest in acromegaly research and treatment. He also speaks with Marvin Avila, an acromegaly patient living in the Washington, DC, metro area. Endocrine Society members, please complete a survey at https://education.endocrine.org/acromegalypodcast (login required), and you will receive a pituitary pin. This episode is supported by Pfizer through an unrestricted, educational grant. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast 2020 endocrine, acromegaly, neuroendocrinology no https://www.endocrine.org/podcast/enp31-closed-loop-glucagon-pump-for-pbh Fri, 20 March 2020 10:00:00 EDT We hear from Christopher Mulla, MD, from the Joslin Diabetes Center in Boston, about his research about the closed loop glucagon pump as a strategy for post-bariatric hypoglycemia. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast. https://www.endocrine.org/-/media/783f395f05054c2c882e3288154939f8.m4a 9:38 We hear from Christopher Mulla, MD, from the Joslin Diabetes Center in Boston, about his research about the closed loop glucagon pump as a strategy for post-bariatric hypoglycemia. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast 2020 endocrine, glucagon, bariatric, obesity, hypoglycemia no https://www.endocrine.org/podcast/enp-32-niddk-and-endocrinology Tue, 21 April 2020 16:00:00 EDT The Endocrine Society’s chief professional and clinical affairs officer, Robert Lash, MD, talks with Griffin Rodgers, MD, director of the NIH’s National Institute of Diabetes and Digestive and Kidney Diseases, and William Cefalu, MD, director of NIDDK’s Division of Diabetes, Endocrinology and Metabolic Disease. They talk about the institute’s mission, the months since Dr. Cefalu took over the division, and their interactions with professional organizations like the Endocrine Society. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast. https://www.endocrine.org/-/media/0e7b91af69974f28a2d05933b8f85023.m4a 24:10 The Endocrine Society’s chief professional and clinical affairs officer, Robert Lash, MD, talks with Griffin Rodgers, MD, director of the NIH’s National Institute of Diabetes and Digestive and Kidney Diseases, and William Cefalu, MD, director of NIDDK’s Division of Diabetes, Endocrinology and Metabolic Disease. They talk about the institute’s mission, the months since Dr. Cefalu took over the division, and their interactions with professional organizations like the Endocrine Society. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast 2020 endocrine, diabetes, national, institutes, health, nih, niddk, advocacy, funding no https://www.endocrine.org/podcast/enp33-thyroid-and-pregnancy Fri, 1 May 2020 11:00:00 EDT Aaron talks about thyroid and pregnancy with Elizabeth Pearce, professor of medicine at Boston University Medical Center and president of the American Thyroid Association. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast. https://www.endocrine.org/-/media/6efc0dcf7f0445b992cba5841c2562f6.m4a 17:55 Aaron talks about thyroid and pregnancy with Elizabeth Pearce, professor of medicine at Boston University Medical Center and president of the American Thyroid Association. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast 2020 endocrine, thyroid, pregnancy, hypothyroid, hyperthyroid no https://www.endocrine.org/podcast/enp34-endocrine-in-the-time-of-covid-part-1 Wed, 3 June 2020 10:20:00 EDT We begin the first in a four-part micro-series on endocrine in the time of COVID. Here Aaron talks with Kathleen Dungan, MD, associate professor of medicine at the Ohio State University Division of Endocrinology, Diabetes, and Metabolism, about what we know right now about the effects of COVID-19 on the patient with diabetes. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast. https://www.endocrine.org/-/media/44e1086849bb4f9f869002e5789e68f3.m4a 17:36 We begin the first in a four-part micro-series on endocrine in the time of COVID. Here Aaron talks with Kathleen Dungan, MD, associate professor of medicine at the Ohio State University Division of Endocrinology, Diabetes, and Metabolism, about what we know right now about the effects of COVID-19 on the patient with diabetes. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast 2020 endocrine, diabetes, covid, covid19, telehealth, pandemic no https://www.endocrine.org/podcast/enp35-endocrine-in-the-time-of-covid-part-2 Wed, 10 June 2020 10:00:00 EDT We continue in our four-part micro-series on endocrine in the time of COVID. Aaron talks some more with Kathleen Dungan, MD, associate professor of medicine at the Ohio State University Division of Endocrinology, Diabetes, and Metabolism, about continuous glucose monitoring, training for caregivers and nurses, and telehealth. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast. https://www.endocrine.org/-/media/4a13c750682348b49e139d58466898bb.m4a 19:31 We continue in our four-part micro-series on endocrine in the time of COVID. Aaron talks some more with Kathleen Dungan, MD, associate professor of medicine at the Ohio State University Division of Endocrinology, Diabetes, and Metabolism, about continuous glucose monitoring, training for caregivers and nurses, and telehealth. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast 2020 endocrine, diabetes, covid, covid19, telehealth, pandemic, glucose, cgm, nursing no https://www.endocrine.org/podcast/enp36-endocrine-in-the-time-of-covid-part-3 Wed, 17 June 2020 10:00:00 EDT We continue in our four-part micro-series on endocrine in the time of COVID. Here Aaron talks about the health disparities we see in the pandemic, especially those affecting African-American patients, with Joshua Joseph, MD, assistant professor of medicine in the Division of Endocrinology, Diabetes, and Metabolism at The Ohio State University Wexner Medical Center. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast. https://www.endocrine.org/-/media/54ab6be81156485999c99526f82bf604.m4a 20:58 We continue in our four-part micro-series on endocrine in the time of COVID. Here Aaron talks about the health disparities we see in the pandemic, especially those affecting African-American patients, with Joshua Joseph, MD, assistant professor of medicine in the Division of Endocrinology, Diabetes, and Metabolism at The Ohio State University Wexner Medical Center. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast 2020 endocrine, diabetes, covid, covid19, telehealth, pandemic, race, disparities, minorities, minority, black, african american, brown, latin, latinx, asian no https://www.endocrine.org/podcast/enp37-endocrine-in-the-time-of-covid-part-4 Wed, 24 June 2020 10:00:00 EDT We continue in our four-part micro-series on endocrine in the time of COVID. Aaron talks more with Joshua Joseph, MD, assistant professor of medicine in the Division of Endocrinology, Diabetes, and Metabolism at The Ohio State University Wexner Medical Center. Dr. Joseph talks about disparities in research funding and the need for mentoring for young researchers, changes in policymaking that helps poor and BIPOC communities, and more engagement by endocrinologists both in the pandemic and in the treatment of all communities. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast. https://www.endocrine.org/-/media/56577786983a45ebbfd683464ab84e77.m4a 22:39 We continue in our four-part micro-series on endocrine in the time of COVID. Aaron talks more with Joshua Joseph, MD, assistant professor of medicine in the Division of Endocrinology, Diabetes, and Metabolism at The Ohio State University Wexner Medical Center. Dr. Joseph talks about disparities in research funding and the need for mentoring for young researchers, changes in policymaking that helps poor and BIPOC communities, and more engagement by endocrinologists both in the pandemic and in the treatment of all communities. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast 2020 endocrine, covid, covid19, pandemic, race, disparities, minorities, minority, black, african american, brown, latin, latinx, asian, funding, advocacy, mentors, mentoring, mentor no https://www.endocrine.org/podcast/enp-38-hypoglycemia Wed, 12 August 2020 10:00:00 EDT Host Aaron Lohr talks about hypoglycemia with Elizabeth Seaquist, MD, from the University of Minnesota, and Cecilia Low Wang, MD, from the University of Colorado Hospital. Drs. Seaquist and Low Wang are the faculty of the ENDO Online 2020 session titled “Severe Hypoglycemia: The Frequently Forgotten Threat.” Once you have listened to the episode, let us know what you think about it by taking a survey, the link to which you can find on our website, https://www.endocrine.org/podcast (click on the episode link). Fill out the survey, and we will send you an insulin pin. This podcast is supported by an unrestricted, educational grant from Lilly. https://www.endocrine.org/-/media/02c5465fa9a64aee8cba0746a87135d2.m4a 24:52 Host Aaron Lohr talks about hypoglycemia with Elizabeth Seaquist, MD, from the University of Minnesota, and Cecilia Low Wang, MD, from the University of Colorado Hospital. Drs. Seaquist and Low Wang are the faculty of the ENDO Online 2020 session titled “Severe Hypoglycemia: The Frequently Forgotten Threat.” Once you have listened to the episode, let us know what you think about it by taking a survey, the link to which you can find on our website, https://www.endocrine.org/podcast (click on the episode link). Fill out the survey, and we will send you an insulin pin. This podcast is supported by an unrestricted, educational grant from Lilly. 2020 endocrine, glucose, glucagon, hypoglycemia, hyperglycemia, blood sugar, covid, covid19 no https://www.endocrine.org/podcast/enp39-whats-new-in-obesity-treatment Fri, 18 September 2020 17:00:00 EDT Hear host Aaron Lohr's talk with Donna Ryan from Pennington Biomedical about the latest developments in obesity treatment. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast. https://www.endocrine.org/-/media/90e72a421b83403aa5639a4ff225bbd5.m4a 19:49 Hear host Aaron Lohr's talk with Donna Ryan from Pennington Biomedical about the latest developments in obesity treatment. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast 2020 endocrine, glucose, glucagon, diabetes; obesity; surgery; orlistat; phentermine; bariatric no https://www.endocrine.org/podcast/enp40-time-in-range Wed, 7 October 2020 10:00:00 EDT Host Aaron Lohr talks about time in range, hypoglycemia, and continuous glucose monitoring with Steven Edelman, MD, and Jeremy Pettus, MD, from the University of California, San Diego, and Rayhan Lal, MD, of Stanford University. Once you finish listening, take a survey, and you will receive a fashionable pancreas pin. The survey and all other links can be found at https://www.endocrine.org/podcast. This episode is sponsored by an unrestricted, educational grant from Novo Nordisk, Abbott Diabetes Care, and Medtronic. https://www.endocrine.org/-/media/f4189c8ca58440dd9f4a4f90f4f3538e.m4a 32:18 Host Aaron Lohr talks about time in range, hypoglycemia, and continuous glucose monitoring with Steven Edelman, MD, and Jeremy Pettus, MD, from the University of California, San Diego, and Rayhan Lal, MD, of Stanford University. Once you finish listening, take a survey, and you will receive a fashionable pancreas pin. The survey and all other links can be found at https://www.endocrine.org/podcast. This episode is sponsored by an unrestricted, educational grant from Novo Nordisk, Abbott Diabetes Care, and Medtronic. 2020 endocrine, glucose, glucagon, hypoglycemia, hyperglycemia, blood sugar, diabetes, cgm, time in range; covid; covid19; coronavirus no https://www.endocrine.org/podcast/enp41-appetite-hormone-responses-to-sugars Tue, 5 January 2021 15:55:00 EST We look at sugars and appetite with Kathleen Page, MD, associate professor of medicine at the University of Southern California Keck School of Medicine. Dr. Page is the corresponding author of a new article published in The Journal of Clinical Endocrinology and Metabolism, “Appetite-Regulating Hormones Are Reduced After Oral Sucrose vs Glucose: Influence of Obesity, Insulin Resistance, and Sex.” For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast. https://www.endocrine.org/-/media/9684f32a9a9346e78f03310462e69ab0.m4a 10:12 We look at sugars and appetite with Kathleen Page, MD, associate professor of medicine at the University of Southern California Keck School of Medicine. Dr. Page is the corresponding author of a new article published in The Journal of Clinical Endocrinology and Metabolism, “Appetite-Regulating Hormones Are Reduced After Oral Sucrose vs Glucose: Influence of Obesity, Insulin Resistance, and Sex.” For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast 2021 endocrine, glucose, sucrose, glucose, hyperglycemia, hypoglycemia, diabetes no https://www.endocrine.org/podcast/enp42-100-years-of-insulin Fri, 22 January 2021 12:30:00 EST Today we celebrate 100 years since the discovery of insulin. We talk with Elizabeth A. Stephens, MD, an endocrinologist with the Providence Medical Group in Portland, Ore., about the importance of this landmark discovery, how it shaped our understanding and treatment of diabetes, and how it sets the stage for the exciting breakthroughs of tomorrow. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast. https://www.endocrine.org/-/media/7b040e94b2894b19860c671844f22853.m4a 16:59 Today we celebrate 100 years since the discovery of insulin. We talk with Elizabeth A. Stephens, MD, an endocrinologist with the Providence Medical Group in Portland, Ore., about the importance of this landmark discovery, how it shaped our understanding and treatment of diabetes, and how it sets the stage for the exciting breakthroughs of tomorrow. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast 2021 endocrine, insulin, glucose; sucrose, hyperglycemia, hypoglycemia, diabetes no https://www.endocrine.org/podcast/enp43-what-to-expect-from-endo-2021 Tue, 9 February 2021 10:00:00 EST The pandemic has changed the world of medical and science conferences, including the Endocrine Society's annual meeting, ENDO 2021, which will be an all-virtual event. Host Aaron Lohr talks with Felix Beuschlein, a professor at University Hospital Zurich and chair of the Society's annual meeting steering committee, about what to expect. ENDO 2021 will be held on March 20-23. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast. https://www.endocrine.org/-/media/b92819856be44f8d943d8f412c4965c1.m4a 16:56 The pandemic has changed the world of medical and science conferences, including the Endocrine Society's annual meeting, ENDO 2021, which will be an all-virtual event. Host Aaron Lohr talks with Felix Beuschlein, a professor at University Hospital Zurich and chair of the Society's annual meeting steering committee, about what to expect. ENDO 2021 will be held on March 20-23. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast 2021 endocrine, endo2021, annual, meeting, virtual, society, diabetes, zoom no https://www.endocrine.org/podcast/enp44-sodium-levels-and-covid-19 Tue, 30 March 2021 10:15:00 EDT A new study in The Journal of Clinical Endocrinology & Metabolism shows the relationship between abnormal sodium levels and greater risk of respiratory failure and death in patients with COVID-19. Host Aaron Lohr speaks with two of the authors, Ploutarchos Tzoulis, MD, PhD, from University College London Medical School and Julian Waung, PhD, from the Whittington Health NHS Trust in London. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast https://www.endocrine.org/-/media/248e420c5efe4e8b9950165757132915.m4a 22:43 A new study in The Journal of Clinical Endocrinology & Metabolism shows the relationship between abnormal sodium levels and greater risk of respiratory failure and death in patients with COVID-19. Host Aaron Lohr speaks with two of the authors, Ploutarchos Tzoulis, MD, PhD, from University College London Medical School and Julian Waung, PhD, from the Whittington Health NHS Trust in London. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast 2021 endocrine, jcem, sodium, covid, covid19, coronavirus, hypernatremia, hyponatremia; dysnatremia; respiratory; failure; hospitalization; morbidity; mortality; sarscov2 no https://www.endocrine.org/podcast/enp45-atypical-thyroiditis-induced-by-covid-19 Tue, 13 April 2021 10:00:00 EDT Host Aaron Lohr talks about thyroiditis and COVID-19 with Ilaria Muller, MD, PhD, from the University of Milan. Dr. Muller presented her research in March at ENDO 2021: “Early Follow-up of Atypical Thyroiditis Induced by SARS-CoV-2.” For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast https://www.endocrine.org/-/media/ac13cd453db6402184ed3af3843ed6e2.m4a 19:45 Host Aaron Lohr talks about thyroiditis and COVID-19 with Ilaria Muller, MD, PhD, from the University of Milan. Dr. Muller presented her research in March at ENDO 2021: “Early Follow-up of Atypical Thyroiditis Induced by SARS-CoV-2.” For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast 2021 endocrine, covid, covid19, coronavirus; sarscov2; thyroid; thyroiditis no https://www.endocrine.org/podcast/enp46-vitamin-d-and-covid Wed, 28 April 2021 10:00:00 EDT Host Aaron Lohr talks about vitamin D insufficiency and COVID-19 with Laurel Mohrmann, MD, and Sweta Chekuri, MD, both from Montefiore Medical Center in the Bronx. Drs. Mohrmann and Chekuri participated on a team that presented in March on vitamin D insufficiency at ENDO 2021. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast https://www.endocrine.org/-/media/50435eae953b4b348bb770b42097a0f7.m4a 13:01 Host Aaron Lohr talks about vitamin D insufficiency and COVID-19 with Laurel Mohrmann, MD, and Sweta Chekuri, MD, both from Montefiore Medical Center in the Bronx. Drs. Mohrmann and Chekuri participated on a team that presented in March on vitamin D insufficiency at ENDO 2021. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast 2021 endocrine, covid, covid19, coronavirus, sarscov2, vitamin, vitamin D, calciferol, deficiency, insufficiency, vitamin d insufficiency, vitamin D deficiency, hypovitaminosis D, rickets, sunlight, sun, osteomalacia, obesity no https://www.endocrine.org/podcast/enp47-obesity-and-infertility Wed, 11 May 2021 10:00:00 EDT Host Aaron Lohr talks about obesity, infertility, and a lifestyle intervention program, Fit for Fertility, presented during the Endocrine Society's annual meeting ENDO 2021 by researchers from the University of Sherbrooke in Canada. Here he speaks with the first author of the presentation, Matea Belan, PhD. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast https://www.endocrine.org/-/media/ea924049d4224abd9b5536c5c32f8063.m4a 15:14 Host Aaron Lohr talks about obesity, infertility, and a lifestyle intervention program, Fit for Fertility, presented during the Endocrine Society's annual meeting ENDO 2021 by researchers from the University of Sherbrooke in Canada. Here he speaks with the first author of the presentation, Matea Belan, PhD. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast 2021 endocrine, endocrinology, obesity, infertility, fertility, female, reproduction, female reproduction no https://www.endocrine.org/podcast/enp48-type-1-diabetes Mon, 13 Sep 2021 14:45:00 EDT We explore type 1 diabetes, everything from diagnosis to treatment strategies, hypoglycemia, technology, and teleheath. Host Aaron Lohr talks with Irl Hirsch, MD, from the University of Washington, and Davida Kruger, NP, from the Henry Ford Health System. They co-chair the Endocrine Society's 8th Annual Endocrine Fellows Type 1 Diabetes Care and Management Program. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast https://www.endocrine.org/-/media/83af38e1ae744529921f03be8ca97d97.m4a 39:43 We explore type 1 diabetes, everything from diagnosis to treatment strategies, hypoglycemia, technology, and teleheath. Host Aaron Lohr talks with Irl Hirsch, MD, from the University of Washington, and Davida Kruger, NP, from the Henry Ford Health System. They co-chair the Endocrine Society's 8th Annual Endocrine Fellows Type 1 Diabetes Care and Management Program. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast 2021 endocrine, endocrinology, obesity, diabetes, t1d, insulin, glucose, cgm, hypoglycemia, telehealth, telemedicine no https://www.endocrine.org/podcast/enp49-cardiovascular-disease-and-type-2-diabetes Mon, 25 Oct 2021 13:00:00 EDT Host Aaron Lohr talks about cardiovascular disease and type 2 diabetes with Jonathan Purnell, MD, from Oregon Health & Science University. Dr. Purnell chaired the Endocrine Society's recent educational series, “Current and Future State of Cardiovascular Disease in Type 2 Diabetes,” which is available through December 2021. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast https://www.endocrine.org/-/media/0767b13410ea4c2386943fd95c2c29f4.m4a 21:13 Host Aaron Lohr talks about cardiovascular disease and type 2 diabetes with Jonathan Purnell, MD, from Oregon Health & Science University. Dr. Purnell chaired the Endocrine Society's recent educational series, “Current and Future State of Cardiovascular Disease in Type 2 Diabetes,” which is available through December 2021. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast 2021 endocrine, endocrinology, obesity, diabetes, t1d, insulin, glucose, cgm, hypoglycemia, telehealth, telemedicine, cardiovascular, heart no https://www.endocrine.org/podcast/enp50-drones-robots-and-diabetes-tech Fri, 5 Nov 2021 11:30:00 EDT For our 50th episode since launching in 2018, host Aaron Lohr takes a look at drone and robotic technology being used for medicine delivery and patient education. He speaks with Derek O’Keeffe, MD, PhD, of the National University of Ireland, Galway, who has been at the forefront of this development in patient care. Dr. O’Keeffe will present on Tuesday, November 9, at the Endocrine Society's upcoming half-day-long, educational event, “Insulin 2121: The Next 100 Years of Discoveries,” which you can register for at https://www.endocrine.org/insulin100 . This episode is sponsored by an unrestricted, educational grant from Lilly USA LLC. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast https://www.endocrine.org/-/media/6bd5e99396f84f558b1d9ec2cf431ee0.m4a 35:34 For our 50th episode since launching in 2018, host Aaron Lohr takes a look at drone and robotic technology being used for medicine delivery and patient education. He speaks with Derek O’Keeffe, MD, PhD, of the National University of Ireland, Galway, who has been at the forefront of this development in patient care. Dr. O’Keeffe will present on Tuesday, November 9, at the Endocrine Society's upcoming half-day-long, educational event, “Insulin 2121: The Next 100 Years of Discoveries,” which you can register for at https://www.endocrine.org/insulin100 . This episode is sponsored by an unrestricted, educational grant from Lilly USA LLC. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast 2021 endocrine, endocrinology, obesity, diabetes, t1d, t2d, insulin, glucose, cgm, drone, robot, robotics no https://www.endocrine.org/podcast/enp51-reevaluating-standards-for-bisphenol-a Fri, 4 Feb 2022 14:30:00 EST In recent years, much attention has been paid to the amount of Bisphenol A, or BPA, an endocrine-disrupting chemical, found in plastic products. But are the standards we have in place enough? Host Aaron Lohr talks with Heather Patisaul, PhD, of North Carolina State University. An Endocrine Society member, Dr. Patisaul is an expert on BPA whose research contributed to findings from a coalition that the Society participated in. This coalition of physicians, scientists, and public health and environmental organizations has petitioned the U.S. Food and Drug Administration to set stricter BPA limits in plastic food containers, among other products. This followed recent, stricter changes in European Union standards for BPA exposure. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast https://www.endocrine.org/-/media/5284822bf48148618ef30b8a2de44064.m4a 12:34 In recent years, much attention has been paid to the amount of Bisphenol A, or BPA, an endocrine-disrupting chemical, found in plastic products. But are the standards we have in place enough? Host Aaron Lohr talks with Heather Patisaul, PhD, of North Carolina State University. An Endocrine Society member, Dr. Patisaul is an expert on BPA whose research contributed to findings from a coalition that the Society participated in. This coalition of physicians, scientists, and public health and environmental organizations has petitioned the U.S. Food and Drug Administration to set stricter BPA limits in plastic food containers, among other products. This followed recent, stricter changes in European Union standards for BPA exposure. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast 2022 endocrine, endocrinology, bisphenol, BPA, bisphenol A, EDC, endocrine disrupting chemicals, estrogen, FDA, plastic, plastics no https://www.endocrine.org/podcast/enp52-incretins-and-type-2-diabetes-management Tue, 29 Mar 2022 11:30:00 EDT Host Aaron Lohr talks about incretins and type 2 diabetes management with Zhenqi Liu, MD, chief of the Division of Endocrinology and Metabolism at the University of Virginia School of Medicine. This episode is certified for up to 0.5 American Medical Association Physician's Recognition Award (AMA PRA) Category 1 credits and American Board of Internal Medicine Maintenance of Certification (ABIM MOC) points. Browse to https://bit.ly/3uEqWto for more information and the certification course. This activity is supported by an educational grant from Lilly. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast https://www.endocrine.org/-/media/b3e3fdf67b9b4f14a2f8e77845511399.m4a 24:52 Host Aaron Lohr talks about incretins and type 2 diabetes management with Zhenqi Liu, MD, chief of the Division of Endocrinology and Metabolism at the University of Virginia School of Medicine. This episode is certified for up to 0.5 American Medical Association Physician's Recognition Award (AMA PRA) Category 1 credits and American Board of Internal Medicine Maintenance of Certification (ABIM MOC) points. Browse to https://bit.ly/3uEqWto for more information and the certification course. This activity is supported by an educational grant from Lilly. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast 2022 endocrine, endocrinology, incretins, twincretins, GIP, GLP1, glucagon, t2d, type 2 diabetes, diabetes, lilly no https://www.endocrine.org/podcast/enp53-ovulatory-disturbances-and-sars-cov2 Wed, 13 Jul 2022 11:00:00 EDT Host Aaron Lohr returns to in-person interviews, starting with the Endocrine Society's 2022 annual meeting in Atlanta. Here he talks about the effects of SARS-COV2 on ovulation with someone we have been talking with since the beginning: Jerilynn C. Prior, MD, professor of endocrinology and metabolism at the University of British Columbia in Vancouver. Dr. Prior and colleagues presented in an oral session during the annual meeting. The abstract is titled “Epidemic of Subclinical Ovulatory Disturbances During SARS-COV2 Pandemic—an Experiment of Nature.” For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast https://www.endocrine.org/-/media/9ffafec62fef4335bfe6f25bd0cb6978.m4a 17:11 Host Aaron Lohr returns to in-person interviews, starting with the Endocrine Society's 2022 annual meeting in Atlanta. Here he talks about the effects of SARS-COV2 on ovulation with someone we have been talking with since the beginning: Jerilynn C. Prior, MD, professor of endocrinology and metabolism at the University of British Columbia in Vancouver. Dr. Prior and colleagues presented in an oral session during the annual meeting. The abstract is titled “Epidemic of Subclinical Ovulatory Disturbances During SARS-COV2 Pandemic—an Experiment of Nature.” For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast 2022 endocrine, endocrinology, ovulation, female reproduction, SARSCOV2, COVID, pandemic no https://www.endocrine.org/podcast/enp54-obesity-pharmacotherapy Wed, 27 Jul 2022 07:30:00 EDT We all know how important diet and exercise are to weight loss and maintenance, but what about anti-obesity medications? How efficient are they? Host Aaron Lohr speaks with Michael Weintraub, MD, clinical fellow in endocrinology, diabetes, and metabolism at New York-Presbyterian Hospital/Weill Cornell Medical Center. Dr. Weintraub and colleagues presented in an oral session during the Endocrine Society's annual meeting. The abstract is titled “Long-term Weight Loss Maintenance with Obesity Pharmacotherapy: a 5-Year Retrospective Study.” For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast https://www.endocrine.org/-/media/9e80235e9ce84c4a82511ccf0767b877.m4a 10:38 We all know how important diet and exercise are to weight loss and maintenance, but what about anti-obesity medications. How efficient are they? Host Aaron Lohr speaks with Michael Weintraub, MD, clinical fellow in endocrinology, diabetes, and metabolism at New York-Presbyterian Hospital/Weill Cornell Medical Center. Dr. Weintraub and colleagues presented in an oral session during the Endocrine Society's annual meeting. The abstract is titled “Long-term Weight Loss Maintenance with Obesity Pharmacotherapy: a 5-Year Retrospective Study.” For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast 2022 endocrine, endocrinology, obesity, pharmacotherapy, lifestyle, weight loss, medication, metformin no https://www.endocrine.org/podcast/enp55-serum-iga-and-t1d-in-children Wed, 10 Aug 2022 19:30:00 EDT In this episode, we talk about a potential marker to help identify youth with type 1 diabetes, islet autoimmunity, and insulin deficiency. This new research was presented at ENDO 2022, and the abstract is titled, “Elevated Serum IgA at Onset of Type 1 Diabetes in Children.” Host Aaron Lohr speaks with one of the authors, Amruta Thakkar, MD, of Texas Children’s Hospital and the Baylor College of Medicine. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast https://www.endocrine.org/-/media/b71dee64b323404fada4005fac09afd8.m4a 9:01 In this episode, we talk about a potential marker to help identify youth with type 1 diabetes, islet autoimmunity, and insulin deficiency. This new research was presented at ENDO 2022, and the abstract is titled, “Elevated Serum IgA at Onset of Type 1 Diabetes in Children.” Host Aaron Lohr speaks with one of the authors, Amruta Thakkar, MD, of Texas Children’s Hospital and the Baylor College of Medicine. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast 2022 endocrine, endocrinology, diabetes, type 1, type 1 diabetes, children, youth, iga, marker, islet autoimmunity, islet, insulin, insulin deficiency no https://www.endocrine.org/podcast/enp56-gestational-diabetes-maternity-blues-and-t2d Wed, 24 Aug 2022 00:00:00 EDT In this episode, Aaron talks with Jennifer Dias from the Icahn School of Medicine at Mount Sinai about gestational diabetes, its association with postpartum depressive symptoms (“maternity blues”), and a predictor that may help prevent gestational diabetes from developing into type 2 diabetes. Ms. Dias, an MD candidate, presented research at ENDO 2022 titled, “Predictors of Postpartum Depressive Symptoms in Women with Recent GDM.” For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast https://www.endocrine.org/-/media/6056b4cd96fd48a1990b794730f9b322.m4a 11:20 In this episode, Aaron talks with Jennifer Dias from the Icahn School of Medicine at Mount Sinai about gestational diabetes, its association with postpartum depressive symptoms (“maternity blues”), and a predictor that may help prevent gestational diabetes from developing into type 2 diabetes. Ms. Dias, an MD candidate, presented research at ENDO 2022 titled, “Predictors of Postpartum Depressive Symptoms in Women with Recent GDM.” For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast 2022 endocrine, endocrinology, diabetes, type 2, type 2 diabetes, gestational, gdm, t2d, gestational diabetes, postpartum, depression, maternity no https://www.endocrine.org/podcast/enp57-male-runners-and-bone-health Wed, 7 Sep 2022 00:00:00 EDT We know that exercise is good for us, but for athletes who run, how might that level of running impact their bones? Host Aaron Lohr talks about new research on this topic presented at ENDO 2022 with one of the study’s presenters, Melanie Schorr Haines, MD, assistant professor of medicine at Massachusetts General Hospital. Dr. Haines and colleagues’ presentation at ENDO 2022 is titled, “Male Runners Have Impaired Tibial Cortical Bone Integrity and Strength Compared to Non-athletes.”For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast https://www.endocrine.org/-/media/c403b8f74e724cbba5dbb6c7ea5be441.m4a 9:36 We know that exercise is good for us, but for athletes who run, how might that level of running impact their bones? Host Aaron Lohr talks about new research on this topic presented at ENDO 2022 with one of the study’s presenters, Melanie Schorr Haines, MD, assistant professor of medicine at Massachusetts General Hospital. Dr. Haines and colleagues’ presentation at ENDO 2022 is titled, “Male Runners Have Impaired Tibial Cortical Bone Integrity and Strength Compared to Non-athletes.” For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast 2022 endocrine, endocrinology, bmi, body mass index, bone, exercise, nutrition, men, runners, running, athlete, athletes no https://www.endocrine.org/podcast/enp58-oncoendocrinology Wed, 21 Sep 2022 00:00:00 EDT Today we shine a spotlight on a fascinating area of focus within endocrinology that maybe you haven't heard much about: oncoendocrinology. What is it, and how are health providers working together to care for patients who have endocrine conditions and cancer? Host Aaron Lohr talks with Afreen I. Shariff, MD, an endocrinologist at Duke University School of Medicine with expertise in endocrine disease in cancer patients. Dr. Shariff is the founding director of the Duke Endocrine-Oncology Program and an associate director for the Cancer Treatment Toxicity Program at the Duke Center for Cancer Immunotherapy. She also chairs the oncoendocrinology special interest group with the Endocrine Society, and she is a host of the podcast “Checkpoint NOW.” For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast https://www.endocrine.org/-/media/f17c08a5dcaa45bc9bcbe04fe086b21a.m4a 16:34 Today we shine a spotlight on a fascinating area of focus within endocrinology that maybe you haven't heard much about: oncoendocrinology. What is it, and how are health providers working together to care for patients who have endocrine conditions and cancer? Host Aaron Lohr talks with Afreen I. Shariff, MD, an endocrinologist at Duke University School of Medicine with expertise in endocrine disease in cancer patients. Dr. Shariff is the founding director of the Duke Endocrine-Oncology Program and an associate director for the Cancer Treatment Toxicity Program at the Duke Center for Cancer Immunotherapy. She also chairs the oncoendocrinology special interest group with the Endocrine Society, and she is a host of the podcast “Checkpoint NOW.” For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast 2022 endocrine, endocrinology, cancer, carcinoma, neoplasia, checkpoint, inhibitor, immunology, pituitary, diabetes, autoimmune, thyroid no https://www.endocrine.org/podcast/enp59-fructose-and-liver-disease Wed, 5 Oct 2022 00:00:00 EDT Fructose is sweeter than glucose and is often added to processed foods as a sweetener, commonly in the form of high-fructose corn syrup. Some studies suggest that fructose consumption may be associated with nonalcoholic fatty liver disease, and some new research, recently presented at ENDO, addresses this issue. Host Aaron Lohr talks with one of the authors of this research, Theodore Friedman, MD, PhD, chairman of internal medicine at Charles R. Drew University of Medicine & Science and professor of medicine at University of California, Los Angeles. Dr. Friedman and colleagues’ oral presentation at ENDO 2022 is titled, “Fructose Consumption in Nonalcoholic Fatty Liver Disease in U.S. Adult Population of NHANES 17-18” (NHANES being a national health and nutrition examination survey). For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast https://www.endocrine.org/-/media/33e407e38245459997cd2e7e35b78cbc.m4a 12:23 Fructose is sweeter than glucose and is often added to processed foods as a sweetener, commonly in the form of high-fructose corn syrup. Some studies suggest that fructose consumption may be associated with nonalcoholic fatty liver disease, and some new research, recently presented at ENDO, addresses this issue. Host Aaron Lohr talks with one of the authors of this research, Theodore Friedman, MD, PhD, chairman of internal medicine at Charles R. Drew University of Medicine & Science and professor of medicine at University of California, Los Angeles. Dr. Friedman and colleagues’ oral presentation at ENDO 2022 is titled, “Fructose Consumption in Nonalcoholic Fatty Liver Disease in U.S. Adult Population of NHANES 17-18” (NHANES being a national health and nutrition examination survey). For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast 2022 endocrine, endocrinology, glucose, fructose, corn, syrup, corn syrup, liver, nafld, nfld, nonalcoholic fatty liver disease, fatty, disease no https://www.endocrine.org/podcast/enp60-cgm-and-prediabetes Wed, 19 Oct 2022 08:30:00 EDT We know how helpful continuous glucose monitors are for individuals with diabetes, but might they be of benefit to individuals with prediabetes? Today host Aaron Lohr will talk with Hisham Farhan, MD, an endocrinology fellow at the University of Maryland Medical Center. Dr. Farhan and colleagues made an oral presentation at ENDO 2022 titled, “Impact of Continuous Glucose Monitoring (CGM) on Lifestyle Modifications in Individuals with Prediabetes.” Show notes are available at https://www.endocrine.org/podcast/enp60-cgm-and-prediabetes — for more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast https://www.endocrine.org/-/media/6a03eaaf37584b2b8ebe8fe2a00ffcd9.m4a 21:30 We know how helpful continuous glucose monitors are for individuals with diabetes, but might they be of benefit to individuals with prediabetes? Today host Aaron Lohr will talk with Hisham Farhan, MD, an endocrinology fellow at the University of Maryland Medical Center. Dr. Farhan and colleagues made an oral presentation at ENDO 2022 titled, “Impact of Continuous Glucose Monitoring (CGM) on Lifestyle Modifications in Individuals with Prediabetes.” Show notes are available at https://www.endocrine.org/podcast/enp60-cgm-and-prediabetes — for more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast 2022 endocrine, endocrinology, glucose, continuous glucose monitoring, cgm, continuous, prediabetes no https://www.endocrine.org/podcast/enp61-islet-cell-transplantation-for-diabetes Wed, 2 Nov 2022 00:00:00 EDT In this episode, we talk about an exciting experimental treatment for patients with type 1 diabetes called islet cell transplantation. Host Aaron Lohr talks with David Baidal, MD, assistant professor of medicine at the University of Miami Miller School of Medicine. This episode is made possible through an unrestricted, educational grant from Vertex Pharmaceuticals. Show notes are available at https://www.endocrine.org/podcast/enp61-islet-cell-transplantation-for-diabetes — for more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast https://www.endocrine.org/-/media/815ae442f5cd4ac28409c28d7281488b.m4a 19:20 In this episode, we talk about an exciting experimental treatment for patients with type 1 diabetes called islet cell transplantation. Host Aaron Lohr talks with David Baidal, MD, assistant professor of medicine at the University of Miami Miller School of Medicine. This episode is made possible through an unrestricted, educational grant from Vertex Pharmaceuticals. Show notes are available at https://www.endocrine.org/podcast/enp61-islet-cell-transplantation-for-diabetes — for more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast 2022 endocrine, endocrinology, diabetes, t1d, type 1 diabetes, islet, transplantation, transplant no https://www.endocrine.org/podcast/enp62-parabens-as-an-edc-and-addressing-disparities-in-risk-and-research Wed, 16 Nov 2022 00:00:00 EST Endocrine-disrupting chemicals are pretty much everywhere, and all of us have some level of exposure. Today we will talk about research presented at ENDO 2022 on a group of EDCs called parabens. The title of that abstract is “Parabens Promote Pro-Tumorigenic Effects in Luminal Breast Cancer Cell Lines With Diverse Genetic Ancestry.” Host Aaron Lohr talks with one of the authors of that study, Lindsey Treviño, PhD, assistant professor at City of Hope National Medical Center. They talk not just about the effects of parabens as an EDC, but also about racial and ethnic disparities in risk and mortality, as well as research, and how Dr. Treviño and colleagues address these disparities. Show notes are available at https://www.endocrine.org/podcast/enp62-parabens-as-an-edc-and-addressing-disparities-in-risk-and-research — for more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast https://www.endocrine.org/-/media/0addfa53c14a4aa1baad6505f3496993.m4a 19:09 Endocrine-disrupting chemicals are pretty much everywhere, and all of us have some level of exposure. Today we will talk about research presented at ENDO 2022 on a group of EDCs called parabens. The title of that abstract is “Parabens Promote Pro-Tumorigenic Effects in Luminal Breast Cancer Cell Lines With Diverse Genetic Ancestry.” Host Aaron Lohr talks with one of the authors of that study, Lindsey Treviño, PhD, assistant professor at City of Hope National Medical Center. They talk not just about the effects of parabens as an EDC, but also about racial and ethnic disparities in risk and mortality, as well as research, and how Dr. Treviño and colleagues address these disparities. Show notes are available at https://www.endocrine.org/podcast/enp62-parabens-as-an-edc-and-addressing-disparities-in-risk-and-research — for more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast 2022 endocrine, endocrinology, diabetes, parabens, disparities, cancer, breast, breast cancer, race, ethnicity, disparity, genetics, ancestry no https://www.endocrine.org/podcast/enp63-vosoritide-and-children-with-genetic-short-stature Wed, 30 Nov 2022 07:00:00 EST We look at Vosoritide, a promising, potential treatment for children with genetic short stature who do not have chondrodysplasia. Host Aaron Lohr talks with Andrew Dauber, MD, division chief of endocrinology at Children’s National Hospital. Dr. Dauber and colleagues presented about Vosoritide at ENDO 2022. Their abstract is titled, “A Prospective Clinical Trial of Vosoritide in Selected Genetic Causes of Short Stature.” Show notes are available at https://www.endocrine.org/podcast/enp63-vosoritide-and-children-with-genetic-short-stature — for more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast https://www.endocrine.org/-/media/b598f90753d94dff8138b096ba9a877c.m4a 14:31 We look at Vosoritide, a promising, potential treatment for children with genetic short stature who do not have chondrodysplasia. Host Aaron Lohr talks with Andrew Dauber, MD, division chief of endocrinology at Children’s National Hospital. Dr. Dauber and colleagues presented about Vosoritide at ENDO 2022. Their abstract is titled, “A Prospective Clinical Trial of Vosoritide in Selected Genetic Causes of Short Stature.” Show notes are available at https://www.endocrine.org/podcast/enp63-vosoritide-and-children-with-genetic-short-stature — for more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast 2022 endocrine, endocrinology, vosoritide, short, stature, pediatric, children, short stature, hypochondroplasia, noonan, noon syndrome, rasopathies, rasopathy, aggrecan, npr2, cnp, shox no https://www.endocrine.org/podcast/enp64-more-testing-needed-for-men-with-hypogonadism Wed, 14 Dec 2022 00:00:00 EST In this episode, Aaron talks with Travis Goettemoeller, MD, internal medicine resident at Cleveland Clinic, about an abstract he and a colleague presented at ENDO 2022 about the bone mineral density testing of men for hypogonadism. The abstract is titled, “Lack of Bone Mineral Density Testing in Men with Hypogonadism: A Clinical Conundrum.” Show notes are available at https://www.endocrine.org/podcast/enp64-more-testing-needed-for-men-with-hypogonadism — for more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast https://www.endocrine.org/-/media/6f93e178e3b24c589ef433cc9f7a78da.m4a 12:03 In this episode, Aaron talks with Travis Goettemoeller, MD, internal medicine resident at Cleveland Clinic, about an abstract he and a colleague presented at ENDO 2022 about the bone mineral density testing of men for hypogonadism. The abstract is titled, “Lack of Bone Mineral Density Testing in Men with Hypogonadism: A Clinical Conundrum.” Show notes are available at https://www.endocrine.org/podcast/enp64-more-testing-needed-for-men-with-hypogonadism — for more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast 2022 endocrine, endocrinology, hypogonadism, gonad, growth, bone, osteoporosis, hypogonad no https://www.endocrine.org/podcast/enp65-type-1-diabetes-and-challenges-across-the-lifespan Wed, 4 Jan 2023 00:00:00 EST In this episode, host Aaron Lohr looks back at the Endocrine Society’s Type 1 Diabetes Fellows Conference, which occurred last year, with two conference presenters talking about developmental challenges in type 1 diabetes, including psychological and social, across the lifespan. Our guests are Linda Siminerio, PhD, professor of medicine at University of Pittsburgh and executive director of the university’s Diabetes Institute, and Jill Weissberg-Benchell, PhD, professor of psychiatry and behavioral sciences at Northwestern University. Dr. Siminerio’s presentation was titled, “Identifying and Confronting Challenging Transitions.” Dr. Weissberg-Benchell’s presentation was titled, “Developmental Perspectives in the Psychosocial Aspects of Diabetes.” Thanks to the conference’s supporters who have made this episode possible through unrestricted, educational grants: Abbott Laboratories, Dexcom, Insulet, Lilly, Medtronic, Novo Nordisk, PreventionBio, and Tandem Diabetes Care. Editor’s note: this interview was recorded in 2022. Show notes are available at https://www.endocrine.org/podcast/enp65-type-1-diabetes-and-challenges-across-the-lifespan — for more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast https://www.endocrine.org/-/media/41b926117d674977b40bf673465434f8.m4a 34:34 In this episode, host Aaron Lohr looks back at the Endocrine Society’s Type 1 Diabetes Fellows Conference, which occurred last year, with two conference presenters talking about developmental challenges in type 1 diabetes, including psychological and social, across the lifespan. Our guests are Linda Siminerio, PhD, professor of medicine at University of Pittsburgh and executive director of the university’s Diabetes Institute, and Jill Weissberg-Benchell, PhD, professor of psychiatry and behavioral sciences at Northwestern University. Dr. Siminerio’s presentation was titled, “Identifying and Confronting Challenging Transitions.” Dr. Weissberg-Benchell’s presentation was titled, “Developmental Perspectives in the Psychosocial Aspects of Diabetes.” Thanks to the conference’s supporters who have made this episode possible through unrestricted, educational grants: Abbott Laboratories, Dexcom, Insulet, Lilly, Medtronic, Novo Nordisk, PreventionBio, and Tandem Diabetes Care. Editor’s note: this interview was recorded in 2022. Show notes are available at https://www.endocrine.org/podcast/enp65-type-1-diabetes-and-challenges-across-the-lifespan — for more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast 2023 endocrine, endocrinology, t1d, type 1, type 1 diabetes, diabetes, lifespan, aging, psychosocial no https://www.endocrine.org/podcast/enp66-new-endocrine-society-journal-jcem-case-reports Wed, 18 Jan 2023 00:00:00 EST The Endocrine Society made news recently by launching a new, online-only, open-access journal called JCEM Case Reports, which is dedicated to clinical cases in endocrinology. What can we learn from case studies, and what does this journal have to offer? To answer those questions, host Aaron Lohr talks with JCEM Case Reports Editor-in-Chief William F. Young Jr., MD, the Tyson Family Endocrinology Clinical Professor and professor of medicine in the Mayo Clinic College of Medicine at Mayo Clinic in Rochester, Minn. Show notes are available at https://www.endocrine.org/podcast/enp66-new-endocrine-society-journal-jcem-case-reports — for more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast https://www.endocrine.org/-/media/6744628192614d8f8628e4ce3610d487.m4a 12:56 The Endocrine Society made news recently by launching a new, online-only, open-access journal called JCEM Case Reports, which is dedicated to clinical cases in endocrinology. What can we learn from case studies, and what does this journal have to offer? To answer those questions, host Aaron Lohr talks with JCEM Case Reports Editor-in-Chief William F. Young Jr., MD, the Tyson Family Endocrinology Clinical Professor and professor of medicine in the Mayo Clinic College of Medicine at Mayo Clinic in Rochester, Minn. Show notes are available at https://www.endocrine.org/podcast/enp66-new-endocrine-society-journal-jcem-case-reports — for more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast 2023 endocrine, endocrinology, jcem, jcemcr, jcem case reports, journal, publications, open access, oa, case, reports, case reports no https://www.endocrine.org/podcast/enp67-growth-hormone-deficiency Wed, 15 Feb 2023 00:00:00 EST In this episode, host Aaron Lohr discusses screening, diagnosis, and current and emerging treatment options for the long-term management of growth hormone deficiency in pediatric and adult patients with Dr. Mark E. Molitch, MD, Professor Emeritus of Medicine, Northwestern University Feinberg School of Medicine. In addition, Dr. Molitch gives listeners a four-question quiz at the end. Remember to pause in between the question and answer! This episode is certified for up to 0.5 American Medical Association Physician’s Recognition Award (AMA PRA) Category 1 credits and American Board of Internal Medicine Maintenance of Certification (ABIM MOC) points. This episode is made possible by an unrestricted, educational grant from Novo Nordisk. Show notes are available at https://www.endocrine.org/podcast/enp67-growth-hormone-deficiency — for helpful links, including to the AMA PRA exam, or to hear more podcast episodes, visit https://www.endocrine.org/podcast https://www.endocrine.org/-/media/92409ea5632a4482b9c5b0eb41955b88.m4a 19:47 In this episode, host Aaron Lohr discusses screening, diagnosis, and current and emerging treatment options for the long-term management of growth hormone deficiency in pediatric and adult patients with Dr. Mark E. Molitch, MD, Professor Emeritus of Medicine, Northwestern University Feinberg School of Medicine. In addition, Dr. Molitch gives listeners a four-question quiz at the end. Remember to pause in between the question and answer! This episode is certified for up to 0.5 American Medical Association Physician’s Recognition Award (AMA PRA) Category 1 credits and American Board of Internal Medicine Maintenance of Certification (ABIM MOC) points. This episode is made possible by an unrestricted, educational grant from Novo Nordisk. Show notes are available at https://www.endocrine.org/podcast/enp67-growth-hormone-deficiency — for helpful links, including to the AMA PRA exam, or to hear more podcast episodes, visit https://www.endocrine.org/podcast 2023 endocrine, endocrinology, growth, hormone, deficiency, ghd, pediatric no https://www.endocrine.org/podcast/enp68-hypercalcemia-of-malignancy Wed, 15 Mar 2023 00:00:00 EST Recently the Endocrine Society published a new clinical practice guideline entitled, “Treatment of Hypercalcemia of Malignancy in Adults: An Endocrine Society Clinical Practice Guideline.” What exactly is hypercalcemia of malignancy? What are its symptoms? How is it treated? And what do the guidelines recommend? To help answer these questions, host Aaron Lohr talks with Ghada El-Hajj Fuleihan, MD, MPH, professor of medicine at the American University in Beirut in Lebanon. She is the chair of the Society working group that developed this guideline. Show notes are available at https://www.endocrine.org/podcast/enp68-hypercalcemia-of-malignancy — for helpful links or to hear more podcast episodes, visit https://www.endocrine.org/podcast https://www.endocrine.org/-/media/9ede94ee97aa464da98a2c13b61243f4.m4a 14:33 Recently the Endocrine Society published a new clinical practice guideline entitled, “Treatment of Hypercalcemia of Malignancy in Adults: An Endocrine Society Clinical Practice Guideline.” What exactly is hypercalcemia of malignancy? What are its symptoms? How is it treated? And what do the guidelines recommend? To help answer these questions, host Aaron Lohr talks with Ghada El-Hajj Fuleihan, MD, MPH, professor of medicine at the American University in Beirut in Lebanon. She is the chair of the Society working group that developed this guideline. Show notes are available at https://www.endocrine.org/podcast/enp68-hypercalcemia-of-malignancy — for helpful links or to hear more podcast episodes, visit https://www.endocrine.org/podcast 2023 endocrine, endocrinology, hypercalcemia, malignancy, hypercalcemia of malignancy, clinical, practice, guideline, bisphosphonate, denosumab, refractory, calcitonin, calcimimetics, GRADE methodology, evidence-to-decision framework, knowledge gaps no https://www.endocrine.org/podcast/enp68-hypercalcemia-of-malignancy Wed, 12 Apr 2023 09:00:00 EDT In this episode, we hear about biosimilar insulin: its safety, efficacy, what sets it apart from biologic insulin, and when it should be considered for use. Host Aaron Lohr talks with Irl Hirsch, MD, professor of medicine at the University of Washington Medicine Diabetes Institute. This episode is made possible through an unrestricted, educational grant from Viatris. Show notes are available at https://www.endocrine.org/podcast/enp69-biosimilar-insulin — for helpful links or to hear more podcast episodes, visit https://www.endocrine.org/podcast https://www.endocrine.org/-/media/d36c9309f64b4c95861cb0af62037ffa.m4a 16:27 In this episode, we hear about biosimilar insulin: its safety, efficacy, what sets it apart from biologic insulin, and when it should be considered for use. Host Aaron Lohr talks with Irl Hirsch, MD, professor of medicine at the University of Washington Medicine Diabetes Institute. This episode is made possible through an unrestricted, educational grant from Viatris. Show notes are available at https://www.endocrine.org/podcast/enp69-biosimilar-insulin — for helpful links or to hear more podcast episodes, visit https://www.endocrine.org/podcast 2023 endocrine, endocrinology, biosimilar, insulin, biosimilar insulin, glargine, fda, food, drug, administration, lispro, aspart, semglee, humalog, nogolog, admelog, basaglar, relion, relion aspart, nph no https://www.endocrine.org/podcast/enp70-hormones-and-aging Wed, 28 Jun 2023 16:00:00 EDT Whether we like it or not, we’re all getting older. What do we know about how aging impacts our endocrine system? What don’t we know? That’s what we’re here to talk about today, as we look at the new scientific statement from the Endocrine Society titled, “Hormones and Aging: An Endocrine Society Scientific Statement.” Host Aaron Lohr talks with one of the statement’s authors, Anne Cappola, MD, a professor of medicine at the University of Pennsylvania and founding director of Penn Medical Communication Research Institute. Show notes are available at https://www.endocrine.org/podcast/enp70-hormones-and-aging — for helpful links or to hear more podcast episodes, visit https://www.endocrine.org/podcast https://www.endocrine.org/-/media/554acff552d74f68adece8479cdd568b.m4a 12:41 Whether we like it or not, we’re all getting older. What do we know about how aging impacts our endocrine system? What don’t we know? That’s what we’re here to talk about today, as we look at the new scientific statement from the Endocrine Society titled, “Hormones and Aging: An Endocrine Society Scientific Statement.” Host Aaron Lohr talks with one of the statement’s authors, Anne Cappola, MD, a professor of medicine at the University of Pennsylvania and founding director of Penn Medical Communication Research Institute. Show notes are available at https://www.endocrine.org/podcast/enp70-hormones-and-aging — for helpful links or to hear more podcast episodes, visit https://www.endocrine.org/podcast 2023 endocrine, endocrinology, adrenal, androgen, estrogen, growth hormone, gh, water metabolism, osteoporosis, thyroid, vitamin D no https://www.endocrine.org/podcast/enp71-lactation-and-maternal-metabolism Wed, 19 Jul 2023 00:00:00 EDT Host Aaron Lohr went to Chicago in June to interview researchers presenting at the Endocrine Society’s annual meeting, ENDO 2023. Here he talks with Julie Hens, PhD, from Yale University about her team’s research, titled “Protective Effects of Lactation on Maternal Metabolism.” After that interview, listen to a sneak peek of our other, members-only podcast, Endocrine Feedback Loop, an episode from November 2022 about changes in glucose throughout the menstrual cycle in type 1 diabetes. Show notes are available at https://www.endocrine.org/podcast/enp71-lactation-and-maternal-metabolism — for helpful links or to hear more podcast episodes, visit https://www.endocrine.org/podcast https://www.endocrine.org/-/media/23e805c679e949f8a1c85d7152e5107a.m4a 12:03 Host Aaron Lohr went to Chicago in June to interview researchers presenting at the Endocrine Society’s annual meeting, ENDO 2023. Here he talks with Julie Hens, PhD, from Yale University about her team’s research, titled “Protective Effects of Lactation on Maternal Metabolism.” After that interview, listen to a sneak peek of our other, members-only podcast, Endocrine Feedback Loop, an episode from November 2022 about changes in glucose throughout the menstrual cycle in type 1 diabetes. Show notes are available at https://www.endocrine.org/podcast/enp71-lactation-and-maternal-metabolism — for helpful links or to hear more podcast episodes, visit https://www.endocrine.org/podcast 2023 endocrine, endocrinology, lactation, milk, breasts, breast, glucose, diabetes, t1d, type 1 diabetes, t1dm, metabolism, menstruation, menstrual, women no https://www.endocrine.org/podcast/enp72-ghr-insulin-and-life-span Wed, 9 Aug 2023 15:00:00 EDT In another interview from ENDO 2023, host Aaron Lohr talks with Silvana Duran Ortiz, Ph.D., a postdoctoral research fellow at Ohio University, about her team’s research presented at the meeting. Their presentation was titled, “Disruption of GHR in ‘Middle Aged’ Mice Enhances Insulin Sensitivity and Extends Male Lifespan.” Show notes are available at https://www.endocrine.org/podcast/enp72-ghr-insulin-and-life-span — for helpful links or to hear more podcast episodes, visit https://www.endocrine.org/podcast https://www.endocrine.org/-/media/d9b2387f69e64142aec31dba3671eb3d.m4a 22:35 In another interview from ENDO 2023, host Aaron Lohr talks with Silvana Duran Ortiz, Ph.D., a postdoctoral research fellow at Ohio University, about her team’s research presented at the meeting. Their presentation was titled, “Disruption of GHR in ‘Middle Aged’ Mice Enhances Insulin Sensitivity and Extends Male Lifespan.” Show notes are available at https://www.endocrine.org/podcast/enp72-ghr-insulin-and-life-span — for helpful links or to hear more podcast episodes, visit https://www.endocrine.org/podcast 2023 endocrine, endocrinology, mice, male, growth hormone receptor, growth, hormone, receptor, insulin no https://www.endocrine.org/podcast/enp73-a-robotic-teriparatide-pill-to-treat-osteoporosis Wed, 23 Aug 2023 00:00:00 EDT Host Aaron Lohr talks with two researchers at ENDO 2023, Kyle Horlen, DVM, and Joshua Myers, both from Rani Therapeutics, about two presentations they made about an oral treatment of teriparatide for the treatment of osteoporosis. The two presentations are titled, “Pharmacokinetics (PK) and Pharmacodynamics (PD) of the Parathyroid Hormone Analog PTH (1-34) (Teriparatide) Delivered via an Orally Administered Robotic Pill (RT-102),” and “An Orally Administered Robotic Pill (RP) Reliably And Safely Delivers the Human Parathyroid Hormone Analog hPTH(1-34) (Teriparatide) With High Bioavailability in Healthy Human Volunteers: A Phase 1 Study.” Show notes are available at https://www.endocrine.org/podcast/enp73-a-robotic-teriparatide-pill-to-treat-osteoporosis — for helpful links or to hear more podcast episodes, visit https://www.endocrine.org/podcast https://www.endocrine.org/-/media/eed9fad0185a46359133f93dd87d1652.m4a 10:43 Host Aaron Lohr talks with two researchers at ENDO 2023, Kyle Horlen, DVM, and Joshua Myers, both from Rani Therapeutics, about two presentations they made about an oral treatment of teriparatide for the treatment of osteoporosis. The two presentations are titled, “Pharmacokinetics (PK) and Pharmacodynamics (PD) of the Parathyroid Hormone Analog PTH (1-34) (Teriparatide) Delivered via an Orally Administered Robotic Pill (RT-102),” and “An Orally Administered Robotic Pill (RP) Reliably And Safely Delivers the Human Parathyroid Hormone Analog hPTH(1-34) (Teriparatide) With High Bioavailability in Healthy Human Volunteers: A Phase 1 Study.” Show notes are available at https://www.endocrine.org/podcast/enp73-a-robotic-teriparatide-pill-to-treat-osteoporosis — for helpful links or to hear more podcast episodes, visit https://www.endocrine.org/podcast 2023 endocrine, endocrinology, osteoporosis, bone, teriparatide, oral, pill, robotic, parathyroid, hormone, pharmacokinetics, pharmacodynamics, analog, hpth, pth, parathyroid hormone analog no https://www.endocrine.org/podcast/enp74-healthy-and-unhealthy-obesity Wed, 6 Sep 2023 08:00:00 EDT In another dispatch from ENDO 2023, host Aaron Lohr talks with Max Petersen, MD, PhD, from Washington University in St. Louis, about his team’s research presented at the meeting. Their presentation was titled, “Cellular Insights Into Metabolically Healthy and Unhealthy Obesity.” Show notes are available at https://www.endocrine.org/podcast/enp74-healthy-and-unhealthy-obesity — for helpful links or to hear more podcast episodes, visit https://www.endocrine.org/podcast https://www.endocrine.org/-/media/c30097bec6234e66b9edf34b768ea124.m4a 11:26 In another dispatch from ENDO 2023, host Aaron Lohr talks with Max Petersen, MD, PhD, from Washington University in St. Louis, about his team’s research presented at the meeting. Their presentation was titled, “Cellular Insights Into Metabolically Healthy and Unhealthy Obesity.” Show notes are available at https://www.endocrine.org/podcast/enp74-healthy-and-unhealthy-obesity — for helpful links or to hear more podcast episodes, visit https://www.endocrine.org/podcast 2023 endocrine, endocrinology, obesity, insulin, diabetes, cellular, metabolism no https://www.endocrine.org/podcast/enp75-a-case-study-on-fungal-sinusitis-in-t2d Wed, 20 Sep 2023 00:00:00 EDT From ENDO 2023, host Aaron Lohr talks with Jayalakshmi Udayasankar, MD, from the Palo Alto Medical Foundation, about her team’s research presented at the meeting, titled, “Tingling Over Cheek: An Atypical Presentation of Invasive Fungal Sinusitis in an Ambulatory Patient With Type 2 Diabetes.” Show notes are available at https://www.endocrine.org/podcast/enp75-a-case-study-on-fungal-sinusitis-in-t2d — for helpful links or to hear more podcast episodes, visit https://www.endocrine.org/podcast https://www.endocrine.org/-/media/25cdef3679f34a899b27cd1e45d9258a.m4a 14:28 From ENDO 2023, host Aaron Lohr talks with Jayalakshmi Udayasankar, MD, from the Palo Alto Medical Foundation, about her team’s research presented at the meeting, titled, “Tingling Over Cheek: An Atypical Presentation of Invasive Fungal Sinusitis in an Ambulatory Patient With Type 2 Diabetes.” Show notes are available at https://www.endocrine.org/podcast/enp75-a-case-study-on-fungal-sinusitis-in-t2d — for helpful links or to hear more podcast episodes, visit https://www.endocrine.org/podcast 2023 endocrine, endocrinology, diabetes, fungus, sinusitis, t2d, type 2 diabetes no https://www.endocrine.org/podcast/enp76-infants-and-in-utero-exposure-to-covid Wed, 4 Oct 2023 00:00:00 EDT Today we look at a study from ENDO 2023 about COVID-19 exposure and weight gain in infants. Host Aaron Lohr talks with Mollie Ockene, a Clinical Research Coordinator at Massachusetts General Hospital and a co-author of the study, titled, “Accelerated Longitudinal Weight Gain Among Infants With In Utero COVID-19 Exposure.” Also, get a sneak peak at an episode of our members-only podcast Endocrine Feedback Loop which looks at a study in The Journal of Clinical Endocrinology & Metabolism about the glycemic gap in hospitalized patients with COVID. Show notes are available at https://www.endocrine.org/podcast/enp76-infants-and-in-utero-exposure-to-covid — for helpful links or to hear more podcast episodes, visit https://www.endocrine.org/podcast https://www.endocrine.org/-/media/5ae8525392324d26868beccf71112a11.m4a 17:35 Today we look at a study from ENDO 2023 about COVID-19 exposure and weight gain in infants. Host Aaron Lohr talks with Mollie Ockene, a Clinical Research Coordinator at Massachusetts General Hospital and a co-author of the study, titled, “Accelerated Longitudinal Weight Gain Among Infants With In Utero COVID-19 Exposure.” Also, get a sneak peak at an episode of our members-only podcast Endocrine Feedback Loop which looks at a study in The Journal of Clinical Endocrinology & Metabolism about the glycemic gap in hospitalized patients with COVID. Show notes are available at https://www.endocrine.org/podcast/enp76-infants-and-in-utero-exposure-to-covid — for helpful links or to hear more podcast episodes, visit https://www.endocrine.org/podcast 2023 endocrine, endocrinology, covid, covid-19, in utero, utero, weight, infants, pediatric no https://www.endocrine.org/podcast/enp77-phthalates-and-endocrine-puberty Wed, 18 Oct 2023 00:00:00 EDT We look at a study, presented at ENDO 2023, about the endocrine-disrupting chemicals known as phthalates, or plasticizers, and their effects on fetal and neonatal endocrine puberty. Host Aaron Lohr talks with Mary Bunnell from the University of Illinois Urbana-Champaign, co-author of the study, titled, “Prenatal Phthalate Exposure Alters the Pattern of Fetal and Neonatal Endocrine Puberty in a Sex-specific Manner.” Show notes are available at https://www.endocrine.org/podcast/enp77-phthalates-and-endocrine-puberty — for helpful links or to hear more podcast episodes, visit https://www.endocrine.org/podcast https://www.endocrine.org/-/media/449a8ade28064334a132cc9b27a486e1.m4a 12:01 We look at a study, presented at ENDO 2023, about the endocrine-disrupting chemicals known as phthalates, or plasticizers, and their effects on fetal and neonatal endocrine puberty. Host Aaron Lohr talks with Mary Bunnell from the University of Illinois Urbana-Champaign, co-author of the study, titled, “Prenatal Phthalate Exposure Alters the Pattern of Fetal and Neonatal Endocrine Puberty in a Sex-specific Manner.” Show notes are available at https://www.endocrine.org/podcast/enp77-phthalates-and-endocrine-puberty — for helpful links or to hear more podcast episodes, visit https://www.endocrine.org/podcast 2023 endocrine, endocrinology, prenatal, fetal, edc, endocrine disrupting chemicals, phthalates no https://www.endocrine.org/podcast/enp78-post-cycle-therapy-following-anabolic-androgenic-steroid-cessation Wed, 1 Nov 2023 00:00:00 EDT We know that illicit use of anabolic-androgenic steroids is dangerous, but cessation comes with its own challenges. Today we’re talking about a study presented at ENDO 2023 titled, “Self-Administration of Post-Cycle Therapy Is Associated With Increased Probability of Subsequent Normalisation of Reproductive Hormones Following Anabolic-Androgenic Steroid Cessation in Men.” Joining host Aaron Lohr to talk about it is one of the study authors, Channa Jayasena, MD, PhD, a specialist in reproductive endocrinology and a research team lead at Imperial College London. Show notes are available at https://www.endocrine.org/podcast/enp78-post-cycle-therapy-following-anabolic-androgenic-steroid-cessation — for helpful links or to hear more podcast episodes, visit https://www.endocrine.org/podcast https://www.endocrine.org/-/media/e4c3bf751e594c968555a10ccac432db.m4a 13:58 We know that illicit use of anabolic-androgenic steroids is dangerous, but cessation comes with its own challenges. Today we’re talking about a study presented at ENDO 2023 titled, “Self-Administration of Post-Cycle Therapy Is Associated With Increased Probability of Subsequent Normalisation of Reproductive Hormones Following Anabolic-Androgenic Steroid Cessation in Men.” Joining host Aaron Lohr to talk about it is one of the study authors, Channa Jayasena, MD, PhD, a specialist in reproductive endocrinology and a research team lead at Imperial College London. Show notes are available at https://www.endocrine.org/podcast/enp78-post-cycle-therapy-following-anabolic-androgenic-steroid-cessation — for helpful links or to hear more podcast episodes, visit https://www.endocrine.org/podcast 2023 endocrine, endocrinology, men, mens, reproductive, anabolic, androgenic, steroid, steroids, post-cycle, post, cycle no https://www.endocrine.org/podcast/enp79-type-1-diabetes-update Wed, 15 Nov 2023 00:00:00 EST Today’s topic is type 1 diabetes. What are some of the biggest challenges facing us today when it comes to diagnosing and treating type 1 diabetes, and how can we meet those challenges? Host Aaron Lohr talks with Irl Hirsch, MD, from the UW Diabetes Institute at the University of Washington. Dr. Hirsch and Davida Kruger, NP, from Henry Ford Health in Detroit co-chaired the Endocrine Society’s type 1 diabetes fellows series. That program and this podcast episode were both made possible by unrestricted, educational grants from Abbott Diabetes Care Inc., CeQur Corp., Dexcom, Insulet, JDRF, Lilly USA LLC, MannKind Corp., Novo Nordisk, Prevention Bio, Vertex, and Tandem Diabetes Care. Show notes are available at https://www.endocrine.org/podcast/enp79-type-1-diabetes-update — for helpful links or to hear more podcast episodes, visit https://www.endocrine.org/podcast https://www.endocrine.org/-/media/3a743f4ea476493a82d09aa2d7e727e5.m4a 35:04 Today’s topic is type 1 diabetes. What are some of the biggest challenges facing us today when it comes to diagnosing and treating type 1 diabetes, and how can we meet those challenges? Host Aaron Lohr talks with Irl Hirsch, MD, from the UW Diabetes Institute at the University of Washington. Dr. Hirsch and Davida Kruger, NP, from Henry Ford Health in Detroit co-chaired the Endocrine Society’s type 1 diabetes fellows series. That program and this podcast episode were both made possible by unrestricted, educational grants from Abbott Diabetes Care Inc., CeQur Corp., Dexcom, Insulet, JDRF, Lilly USA LLC, MannKind Corp., Novo Nordisk, Prevention Bio, Vertex, and Tandem Diabetes Care. Show notes are available at https://www.endocrine.org/podcast/enp79-type-1-diabetes-update — for helpful links or to hear more podcast episodes, visit https://www.endocrine.org/podcast 2023 endocrine, endocrinology, t1d, type 1 diabetes, diabetes, endocrine society, fellows, glucose, metabolism, cgm, continuous glucose monitoring, primary care physician no https://www.endocrine.org/podcast/enp80-metabolic-and-neuroendocrine-effects-of-short-sleep Wed, 29 Nov 2023 00:00:00 EST We all know that sleep is important, but sometimes we just don’t get enough. We also know the normal side effects from lack of sleep, but are there other, metabolic, and neuronendocrine effects from short sleep that we don’t know about. Host Aaron Lohr talks about this with Iris CM Pelsma, an academic researcher at Leiden University Medical Center in the Netherlands. She and her colleagues presented a study earlier this year, at ENDO 2023, titled, “Metabolic and Neuroendocrine Adaptability Following One Night of Partial Sleep Restriction in Dutch Males.” Show notes are available at https://www.endocrine.org/podcast/enp80-metabolic-and-neuroendocrine-effects-of-short-sleep — for helpful links or to hear more podcast episodes, visit https://www.endocrine.org/podcast https://www.endocrine.org/-/media/333b7598066b422e88e3a05aa0a5b87b.m4a 18:39 We all know that sleep is important, but sometimes we just don’t get enough. We also know the normal side effects from lack of sleep, but are there other, metabolic, and neuronendocrine effects from short sleep that we don’t know about. Host Aaron Lohr talks about this with Iris CM Pelsma, an academic researcher at Leiden University Medical Center in the Netherlands. She and her colleagues presented a study earlier this year, at ENDO 2023, titled, “Metabolic and Neuroendocrine Adaptability Following One Night of Partial Sleep Restriction in Dutch Males.” Show notes are available at https://www.endocrine.org/podcast/enp80-metabolic-and-neuroendocrine-effects-of-short-sleep — for helpful links or to hear more podcast episodes, visit https://www.endocrine.org/podcast 2023 endocrine, endocrinology, t1d, type 1 diabetes, diabetes, t2d, type 2 diabetes, glucose, metabolism, neuroendocrine, neuroendocrinology, sleep, short sleep no https://www.endocrine.org/podcast/enp81-obesity-fellows-program Wed, 20 Dec 2023 00:00:00 EST According to the National Institutes of Health, more than two in five adults have obesity in the United States, and nearly one in three is overweight. To equip health care practitioners with the resources they need to treat patients with obesity, the Endocrine Society recently held its innaugual obesity fellows program, an exclusive, application-based, educational activity for current fellows. The program covered a wealth of information, and host Aaron Lohr talks with Amy Rothberg, MD, DABOM, program chair and a clinical professor of internal medicine at the University of Michigan’s School of Public Health. If you weren’t able to attend the fellows program, we have a free series of on-demand lectures available online, and those are accredited. With thanks to Lilly USA LLC and Novo Nordisk for making both the obesity fellows program and this podcast episode possible through an unrestricted, educational grant. Show notes, including a link to the Endocrine Society Learning Center for earning ABIM points and AMA PRA Category 1 credits, are available at https://www.endocrine.org/podcast/enp81-obesity-fellows-program — for helpful links or to hear more podcast episodes, visit https://www.endocrine.org/podcast https://www.endocrine.org/-/media/f5cbbd99488c4166b232e95f6d16c544.m4a 12:10 According to the National Institutes of Health, more than two in five adults have obesity in the United States, and nearly one in three is overweight. To equip health care practitioners with the resources they need to treat patients with obesity, the Endocrine Society recently held its innaugual obesity fellows program, an exclusive, application-based, educational activity for current fellows. The program covered a wealth of information, and host Aaron Lohr talks with Amy Rothberg, MD, DABOM, program chair and a clinical professor of internal medicine at the University of Michigan’s School of Public Health. If you weren’t able to attend the fellows program, we have a free series of on-demand lectures available online, and those are accredited. With thanks to Lilly USA LLC and Novo Nordisk for making both the obesity fellows program and this podcast episode possible through an unrestricted, educational grant. Show notes, including a link to the Endocrine Society Learning Center for earning ABIM points and AMA PRA Category 1 credits, are available at https://www.endocrine.org/podcast/enp81-obesity-fellows-program — for helpful links or to hear more podcast episodes, visit https://www.endocrine.org/podcast 2023 endocrine, endocrinology, obesity, adipose, adiposity, diabetes, t2d, type 2 diabetes, glucose, metabolism, endocrine society, fellows no https://www.endocrine.org/podcast/enp82-pfas Wed, 17 Jan 2024 12:35:00 EST In this episode, we learn about endocrine-disrupting chemicals known as perfluoroalkyl and polyfluoroalkyl substances (PFAS), which break down so slowly that they have been called “forever chemicals.” Where can PFAS be found? What exactly is their effect on human health? What are manufacturers doing to limit exposure, and is it enough? Host Aaron Lohr talks with Benson T. Akingbemi, PhD, professor of anatomy and developmental biology at Auburn University. Dr. Akingbemi and colleagues recently published an article on PFAS in the journal Endocrinology titled, “Legacy and Emerging Perfluoroalkyl and Polyfluoroalkyl Substances Regulate Steroidogenesis in the Male Gonad.” Show notes are available at https://www.endocrine.org/podcast/enp82-pfas — for helpful links or to hear more podcast episodes, visit https://www.endocrine.org/podcast https://www.endocrine.org/-/media/18032db3fdb044c7a7b59c2d3179b8b8.m4a 19:03 In this episode, we learn about endocrine-disrupting chemicals known as perfluoroalkyl and polyfluoroalkyl substances (PFAS), which break down so slowly that they have been called “forever chemicals.” Where can PFAS be found? What exactly is their effect on human health? What are manufacturers doing to limit exposure, and is it enough? Host Aaron Lohr talks with Benson T. Akingbemi, PhD, professor of anatomy and developmental biology at Auburn University. Dr. Akingbemi and colleagues recently published an article on PFAS in the journal Endocrinology titled, “Legacy and Emerging Perfluoroalkyl and Polyfluoroalkyl Substances Regulate Steroidogenesis in the Male Gonad.” Show notes are available at https://www.endocrine.org/podcast/enp82-pfas — for helpful links or to hear more podcast episodes, visit https://www.endocrine.org/podcast 2024 endocrine, endocrinology, perfluoroalkyl, polyfluoroalkyl, pfas, endocrine disrupting chemicals, edc, steroidogenesis, male reproduction, testes, testosterone, gonad, male no https://www.endocrine.org/podcast/enp83-sedentary-time-and-physical-activity-effects-on-childhood-lipid-levels Wed, 7 Feb 2024 00:00:00 EST We all know that a sedentary lifestyle is not healthy for anyone, but just how strongly is physical activity connected to lipid levels in childhood? Host Aaron Lohr talks with Andrew Agbaje, MD, PhD, a physician and pediatric clinical epidemiologist at the University of Eastern Finland. He has authored a study recently published in The Journal of Clinical Endocrinology & Metabolism titled, “Associations of Sedentary Time and Physical Activity From Childhood With Lipids: A 13-Year Mediation and Temporal Study.” Show notes are available at https://www.endocrine.org/podcast/enp83-sedentary-time-and-physical-activity-effects-on-childhood-lipid-levels — for helpful links or to hear more podcast episodes, visit https://www.endocrine.org/podcast https://www.endocrine.org/-/media/dcc6d68a6c87481d9d8638a35abf77f6.m4a 20:18 We all know that a sedentary lifestyle is not healthy for anyone, but just how strongly is physical activity connected to lipid levels in childhood? Host Aaron Lohr talks with Andrew Agbaje, MD, PhD, a physician and pediatric clinical epidemiologist at the University of Eastern Finland. He has authored a study recently published in The Journal of Clinical Endocrinology & Metabolism titled, “Associations of Sedentary Time and Physical Activity From Childhood With Lipids: A 13-Year Mediation and Temporal Study.” Show notes are available at https://www.endocrine.org/podcast/enp83-sedentary-time-and-physical-activity-effects-on-childhood-lipid-levels — for helpful links or to hear more podcast episodes, visit https://www.endocrine.org/podcast 2024 endocrine, endocrinology, pediatrics, lipids, growth, cholesterol, development, dyslipidemia, movement behavior, body composition, obesity, sedentary, lifestyle modification no https://www.endocrine.org/podcast/enp84-fibrodysplasia-ossificans-progressiva Fri, 26 Apr 2024 12:30:00 EDT To claim educational credit, please follow the link to the show notes. In a special episode, we discuss a complex, rare disease, fibrodysplasia ossificans progressiva, or FOP. Host Aaron Lohr talks with three guests: Eileen M. Shore, PhD, Cali and Weldon Research Professor in FOP and co-director of the Center for Research in FOP and Related Disorders at the University of Pennsylvania School of Medicine; Elisabeth Marelise W. Eekhoff, MD, PhD, endocrinologist, principal investigator, and medical specialist at Amsterdam University Medical Center in the Netherlands; and Michelle Davis, executive director of the International Fibrodysplasia Ossificans Progressiva Association. This episode is certified for 0.5 American Medical Association Physician’s Recognition Award (AMA PRA) Category 1™ credits and 0.5 American Board of Internal Medicine Maintenance of Certification (ABIM MOC) points. If you want those credits and points, you will have to browse to the Endocrine Society’s Center for Learning, take a pre-test, listen to this episode there, then take a post-test. This episode is supported by an educational grant from Ipsen Biopharmaceuticals Inc. Show notes, including link to the Center for Learning, are available at https://www.endocrine.org/podcast/enp84-fibrodysplasia-ossificans-progressiva — for helpful links or to hear more podcast episodes, visit https://www.endocrine.org/podcast https://www.endocrine.org/-/media/f5c8c265b0bf41b39e54354687d34a1d.m4a 22:05 To claim educational credit, please follow the link to the show notes below. In a special episode, we discuss a complex, rare disease, fibrodysplasia ossificans progressiva, or FOP. Host Aaron Lohr talks with three guests: Eileen M. Shore, PhD, Cali and Weldon Research Professor in FOP and co-director of the Center for Research in FOP and Related Disorders at the University of Pennsylvania School of Medicine; Elisabeth Marelise W. Eekhoff, MD, PhD, endocrinologist, principal investigator, and medical specialist at Amsterdam University Medical Center in the Netherlands; and Michelle Davis, executive director of the International Fibrodysplasia Ossificans Progressiva Association. This episode is certified for 0.5 American Medical Association Physician’s Recognition Award (AMA PRA) Category 1™ credits and 0.5 American Board of Internal Medicine Maintenance of Certification (ABIM MOC) points. If you want those credits and points, you will have to browse to the Endocrine Society’s Center for Learning, take a pre-test, listen to this episode there, then take a post-test. This episode is supported by an educational grant from Ipsen Biopharmaceuticals Inc. Show notes, including link to the Center for Learning, are available at https://www.endocrine.org/podcast/enp84-fibrodysplasia-ossificans-progressiva — for helpful links or to hear more podcast episodes, visit https://www.endocrine.org/podcast 2024 endocrine, endocrinology, pediatrics, growth, development, fop, bone, fibrodysplasia ossificans progressiva, fibrodysplasia, ossificans, progressiva no https://www.endocrine.org/podcast/enp85-treat-and-reduce-obesity-act Wed, 26 Jun 2024 00:00:00 EDT In this episode, we focus on the Treat and Reduce Obesity Act legislation and the obesity epidemic. Host Aaron Lohr talks with U.S. Rep. Raul Ruiz, MD, a physician and currently the U.S. Representative for California’s 25th congressional district. Rep. Ruiz received his medical degree from Harvard University and completed his residency in emergency medicine at the University of Pittsburgh and a fellowship in international emergency medicine at Brigham and Women’s Hospital in Massachusetts. He worked as an emergency room doctor at Eisenhower Medical Center in Rancho Mirage, Calif., until he was elected to Congress in 2012. Rep. Ruiz talks about his background, his experience in treating obesity and its comorbidities, and the Treat and Reduce Obesity Act of 2023. Support for this podcast was provided by Eli Lilly & Company. Show notes are available at https://www.endocrine.org/podcast/enp85-treat-and-reduce-obesity-act — for helpful links or to hear more podcast episodes, visit https://www.endocrine.org/podcast https://www.endocrine.org/-/media/94bd305ce6244914b7ed6cda0232c735.m4a 13:25 In this episode, we focus on the Treat and Reduce Obesity Act legislation and the obesity epidemic. Host Aaron Lohr talks with U.S. Rep. Raul Ruiz, MD, a physician and currently the U.S. Representative for California’s 25th congressional district. Rep. Ruiz received his medical degree from Harvard University and completed his residency in emergency medicine at the University of Pittsburgh and a fellowship in international emergency medicine at Brigham and Women’s Hospital in Massachusetts. He worked as an emergency room doctor at Eisenhower Medical Center in Rancho Mirage, Calif., until he was elected to Congress in 2012. Rep. Ruiz talks about his background, his experience in treating obesity and its comorbidities, and the Treat and Reduce Obesity Act of 2023. Support for this podcast was provided by Eli Lilly & Company. Show notes are available at https://www.endocrine.org/podcast/enp85-treat-and-reduce-obesity-act — for helpful links or to hear more podcast episodes, visit https://www.endocrine.org/podcast 2024 endocrine, endocrinology, growth, development, obesity, diabetes, troa, treat and reduce obesity act, congress, congressman, raul ruiz, raul, ruiz no https://www.endocrine.org/podcast/enp86-machine-learning-and-steatotic-liver-disease Wed, 10 Jul 2024 00:00:00 EDT This episode focuses on machine learning and how it may help diagnose metabolic dysfunction-associated steatotic liver disease (MASLD). Host Aaron Lohr talks with Christos S. Mantzoros, MD, PhD, professor of medicine at Harvard Medical School and the editor-in-chief of the journal Metabolism. Dr. Mantzoros and his team presented their work at ENDO 2024 in Boston, and their abstract was title, “Accurate machine-learning-based diagnosis of at-risk MASH and MASLD subtypes using categorical, radiant boosting, and select clinical, biochemical, and metabolomic measurements: Building highly robust models with few variables through a multi-national, multi-center, biopsy-proven cohort.” Show notes are available at https://www.endocrine.org/podcast/enp86-machine-learning-and-steatotic-liver-disease — for helpful links or to hear more podcast episodes, visit https://www.endocrine.org/podcast https://www.endocrine.org/-/media/1f4c57a4bb9c432f8296e18afe545934.m4a 18:39 This episode focuses on machine learning and how it may help diagnose metabolic dysfunction-associated steatotic liver disease (MASLD). Host Aaron Lohr talks with Christos S. Mantzoros, MD, PhD, professor of medicine at Harvard Medical School and the editor-in-chief of the journal Metabolism. Dr. Mantzoros and his team presented their work at ENDO 2024 in Boston, and their abstract was title, “Accurate machine-learning-based diagnosis of at-risk MASH and MASLD subtypes using categorical, radiant boosting, and select clinical, biochemical, and metabolomic measurements: Building highly robust models with few variables through a multi-national, multi-center, biopsy-proven cohort.” Show notes are available at https://www.endocrine.org/podcast/enp86-machine-learning-and-steatotic-liver-disease — for helpful links or to hear more podcast episodes, visit https://www.endocrine.org/podcast 2024 endocrine, endocrinology, growth, development, obesity, diabetes, masld, mash, steatotic, liver, ml, machine learning, artificial intelligence, ai, endo 2024 no https://www.endocrine.org/podcast/enp87-short-term-weight-loss-in-adolescents-with-obesity Wed, 24 Jul 2024 00:00:00 EDT For those of us who try to lose weight at some point in time, we know the frustration of losing weight and feeling good about that, only to see that weight return. Why does that happen? Is the process the same for adults and adolescents? Is there any way to mitigate that weight regain? Joining host Aaron Lohr is Eric Bomberg, MD, assistant professor at the Center for Pediatric Obesity Medicine at the University of Minnesota. Dr. Bomberg recently presented an abstract at ENDO 2024 titled, “Hormonal and Physiological Changes Following Short-Term Weight Loss in Adolescents With Obesity and the Role of Glucagon-Like Peptide 1 Receptor Agonist to Counteract Adaptations.” Show notes are available at https://www.endocrine.org/podcast/enp87-short-term-weight-loss-in-adolescents-with-obesity — for helpful links or to hear more podcast episodes, visit https://www.endocrine.org/podcast https://www.endocrine.org/-/media/5e32b977889b4d9c953c6fed3c9c6eb5.m4a 14:11 For those of us who try to lose weight at some point in time, we know the frustration of losing weight and feeling good about that, only to see that weight return. Why does that happen? Is the process the same for adults and adolescents? Is there any way to mitigate that weight regain? Joining host Aaron Lohr is Eric Bomberg, MD, assistant professor at the Center for Pediatric Obesity Medicine at the University of Minnesota. Dr. Bomberg recently presented an abstract at ENDO 2024 titled, “Hormonal and Physiological Changes Following Short-Term Weight Loss in Adolescents With Obesity and the Role of Glucagon-Like Peptide 1 Receptor Agonist to Counteract Adaptations.” Show notes are available at https://www.endocrine.org/podcast/enp87-short-term-weight-loss-in-adolescents-with-obesity — for helpful links or to hear more podcast episodes, visit https://www.endocrine.org/podcast 2024 endocrine, endocrinology, growth, development, obesity, pediatric, adolescents, glp1, glucagon, peptide, glp-1, weight loss, endo 2024 no https://www.endocrine.org/podcast/enp88-glucocorticoids-in-supplements Wed, 7 Aug 2024 00:00:00 EDT Many people take over-the-counter supplements for a variety of reasons, but it isn’t always clear what’s in those supplements. And while they may be intended to help, some may cause harm. In this episode, host Aaron Lohr talks with Kevin Wei, MD, from the University of Southern California/Los Angeles General Medical Center Internal Medicine Residency Program about the presence of glucocorticoids in some over-the counter supplements and why that may be a concern. Dr. Wei and colleagues presented an abstract at ENDO 2024 titled, “Characterizing the Physiological Side Effects of Over-the-Counter Arthritis Supplements.” Show notes are available at https://www.endocrine.org/podcast/enp88-glucocorticoids-in-supplements — for helpful links or to hear more podcast episodes, visit https://www.endocrine.org/podcast https://www.endocrine.org/-/media/aebfd208a9e24ad591ddc42a96558204.m4a 14:20 Many people take over-the-counter supplements for a variety of reasons, but it isn’t always clear what’s in those supplements. And while they may be intended to help, some may cause harm. In this episode, host Aaron Lohr talks with Kevin Wei, MD, from the University of Southern California/Los Angeles General Medical Center Internal Medicine Residency Program about the presence of glucocorticoids in some over-the counter supplements and why that may be a concern. Dr. Wei and colleagues presented an abstract at ENDO 2024 titled, “Characterizing the Physiological Side Effects of Over-the-Counter Arthritis Supplements.” Show notes are available at https://www.endocrine.org/podcast/enp88-glucocorticoids-in-supplements — for helpful links or to hear more podcast episodes, visit https://www.endocrine.org/podcast 2024 endocrine, endocrinology, glucocorticoids, otc, supplement, supplements, adrenal, endo 2024 no https://www.endocrine.org/podcast/enp89-brown-fat-and-metabolic-function Wed, 21 Aug 2024 00:00:00 EDT In this episode, we talk about brown fat and some new discoveries in how it regulates metabolic function. Joining host Aaron Lohr is Marsel Lino, PhD, a research fellow at Joslin Diabetes Center in Boston. Dr. Lino presented an abstract at ENDO 2024 titled, “A New Layer of Endocrine Regulation: Brown Fat Secretes Exosomal MicroRNAs, Which Regulate Metabolic Functions and Distal Organs.” Show notes are available at https://www.endocrine.org/podcast/enp89-brown-fat-and-metabolic-function — for helpful links or to hear more podcast episodes, visit https://www.endocrine.org/podcast https://www.endocrine.org/-/media/f40f5a08cc344297ac828f54f6b8b37e.m4a 15:36 In this episode, we talk about brown fat and some new discoveries in how it regulates metabolic function. Joining host Aaron Lohr is Marsel Lino, PhD, a research fellow at Joslin Diabetes Center in Boston. Dr. Lino presented an abstract at ENDO 2024 titled, “A New Layer of Endocrine Regulation: Brown Fat Secretes Exosomal MicroRNAs, Which Regulate Metabolic Functions and Distal Organs.” Show notes are available at https://www.endocrine.org/podcast/enp89-brown-fat-and-metabolic-function — for helpful links or to hear more podcast episodes, visit https://www.endocrine.org/podcast 2024 endocrine, endocrinology, brown, fat, brown fat, obesity, adrenal, adipose, endo 2024 no https://www.endocrine.org/podcast/enp90-early-life-stress-and-substance-use Wed, 4 Sep 2024 00:00:00 EDT We all know that stress leads to a number of negative outcomes. In this episode, we talk about how early life stress may influence youth substance use initiation and some endocrine factors that may be helping to drive that influence. Host Aaron Lohr talks with Alexandra M. Donovan, PhD, of the Charles R. Drew University of Medicine and Science. Dr. Donovan recently presented an abstract at ENDO 2024 titled, “Early Life Stress and Pubertal Predictors of Youth Substance Use Initiation: Does Sex Moderate the Relationship Between Early Life Stress, Puberty, and Substance Use Initiation?” Show notes are available at https://www.endocrine.org/podcast/enp90-early-life-stress-and-substance-use — for helpful links or to hear more podcast episodes, visit https://www.endocrine.org/podcast https://www.endocrine.org/-/media/bce6618d769d40fc9d0e84ca38b955f0.m4a 25:01 We all know that stress leads to a number of negative outcomes. In this episode, we talk about how early life stress may influence youth substance use initiation and some endocrine factors that may be helping to drive that influence. Host Aaron Lohr talks with Alexandra M. Donovan, PhD, of the Charles R. Drew University of Medicine and Science. Dr. Donovan recently presented an abstract at ENDO 2024 titled, “Early Life Stress and Pubertal Predictors of Youth Substance Use Initiation: Does Sex Moderate the Relationship Between Early Life Stress, Puberty, and Substance Use Initiation?” Show notes are available at https://www.endocrine.org/podcast/enp90-early-life-stress-and-substance-use — for helpful links or to hear more podcast episodes, visit https://www.endocrine.org/podcast 2024 endocrine, endocrinology, stress, abuse, child abuse, domestic abuse, drug abuse, growth, development, trauma no https://www.endocrine.org/podcast/enp91-hypothyroidism-and-muscle-regeneration Wed, 18 Sep 2024 00:00:00 EDT Our bodies typically do a remarkable job of recovering from certain injuries, and thyroid hormone signaling has an essential role to play there. But what is that process like for someone with hypothyroidism, and is there a unique role in that process for muscle stem cells? Host Aaron Lohr talks with Paola Aguiari, PhD, a senior research specialist at Children’s Hospital Los Angeles. She presented an abstract at ENDO 2024 titled, “Hypothyroidism Impairs Skeletal Muscle Regeneration After Injury.” Show notes are available at https://www.endocrine.org/podcast/enp91-hypothyroidism-and-muscle-regeneration — for helpful links or to hear more podcast episodes, visit https://www.endocrine.org/podcast https://www.endocrine.org/-/media/b3a9cdb4b95c4f4baef212d1bb31b522.m4a 11:24 Our bodies typically do a remarkable job of recovering from certain injuries, and thyroid hormone signaling has an essential role to play there. But what is that process like for someone with hypothyroidism, and is there a unique role in that process for muscle stem cells? Host Aaron Lohr talks with Paola Aguiari, PhD, a senior research specialist at Children’s Hospital Los Angeles. She presented an abstract at ENDO 2024 titled, “Hypothyroidism Impairs Skeletal Muscle Regeneration After Injury.” Show notes are available at https://www.endocrine.org/podcast/enp91-hypothyroidism-and-muscle-regeneration — for helpful links or to hear more podcast episodes, visit https://www.endocrine.org/podcast 2024 endocrine, endocrinology, thyroid, bone, hypothyroidism, hypothyroid, muscle, regeneration, muscle regeneration, skeletal, injury no https://www.endocrine.org/podcast/enp92-pheochromocytomas Wed, 2 Oct 2024 00:00:00 EDT In this episode, we talk about pheochromocytomas. Host Aaron Lohr talks with Nikhitha Chandrashekar, MD, who recently finished her endocrinology fellowship at University Hospitals Case Western Reserve University in Cleveland. Dr. Chandrashekar presented a case study on pheochromocytomas at ENDO 2024. Show notes are available at https://www.endocrine.org/podcast/enp92-pheochromocytomas — for helpful links or to hear more podcast episodes, visit https://www.endocrine.org/podcast https://www.endocrine.org/-/media/2c38cf9e269d43468bc3c82dd3370093.m4a 12:00 In this episode, we talk about pheochromocytomas. Host Aaron Lohr talks with Nikhitha Chandrashekar, MD, who recently finished her endocrinology fellowship at University Hospitals Case Western Reserve University in Cleveland. Dr. Chandrashekar presented a case study on pheochromocytomas at ENDO 2024. Show notes are available at https://www.endocrine.org/podcast/enp92-pheochromocytomas — for helpful links or to hear more podcast episodes, visit https://www.endocrine.org/podcast 2024 endocrine, endocrinology, pheochromocytoma, pheochromocytomas, adrenal, medication, cancer, tumor no https://www.endocrine.org/podcast/enp93-patience-experience-in-managing-diabetes Wed, 16 Oct 2024 00:00:00 EDT Host Aaron Lohr talks with Rita Kalyani, MD, professor of medicine at Johns Hopkins University School of Medicine and president-elect of medicine and science at the American Diabetes Association. Earlier this year, Dr. Kalyani and colleagues published a position statement in The Journal of Clinical Endocrinology & Metabolism titled, “Prioritizing Patient Experiences in the Management of Diabetes and Its Complications: An Endocrine Society Position Statement.” Show notes are available at https://www.endocrine.org/podcast/enp93-patience-experience-in-managing-diabetes — for helpful links or to hear more podcast episodes, visit https://www.endocrine.org/podcast https://www.endocrine.org/-/media/ef89da2ee1824b01889b1ff0a4faa16c.m4a 27:28 Host Aaron Lohr talks with Rita Kalyani, MD, professor of medicine at Johns Hopkins University School of Medicine and president-elect of medicine and science at the American Diabetes Association. Earlier this year, Dr. Kalyani and colleagues published a position statement in The Journal of Clinical Endocrinology & Metabolism titled, “Prioritizing Patient Experiences in the Management of Diabetes and Its Complications: An Endocrine Society Position Statement.” Show notes are available at https://www.endocrine.org/podcast/enp93-patience-experience-in-managing-diabetes — for helpful links or to hear more podcast episodes, visit https://www.endocrine.org/podcast 2024 endocrine, endocrinology, diabetes, patient, patient care, obesity, management, patient experience, endocrine society no https://www.endocrine.org/podcast/enp94-update-on-acromegaly Wed, 13 Nov 2024 00:00:00 EST It’s been a few years, but we are here with an update on acromegaly, covering prevalence, diagnosis, traditional treatment, new therapies, and current gaps in understanding. Host Aaron Lohr talks again with Maria Fleseriu, MD, professor of medicine and professor of neurological surgery at Oregon Health & Science University School of Medicine and director of OHSU’s Pituitary Center. Dr. Fleseriu also serves on the Board of Directors of the Endocrine Society. Show notes are available at https://www.endocrine.org/podcast/enp94-update-on-acromegaly — for helpful links or to hear more podcast episodes, visit https://www.endocrine.org/podcast https://www.endocrine.org/-/media/bc99e7310f2d453e847ecd0a700b38a9.m4a 34:23 It’s been a few years, but we are here with an update on acromegaly, covering prevalence, diagnosis, traditional treatment, new therapies, and current gaps in understanding. Host Aaron Lohr talks again with Maria Fleseriu, MD, professor of medicine and professor of neurological surgery at Oregon Health & Science University School of Medicine and director of OHSU’s Pituitary Center. Dr. Fleseriu also serves on the Board of Directors of the Endocrine Society. Show notes are available at https://www.endocrine.org/podcast/enp94-update-on-acromegaly — for helpful links or to hear more podcast episodes, visit https://www.endocrine.org/podcast 2024 endocrine, endocrinology, acromegaly, adrenal, growth, development, tumor no https://www.endocrine.org/podcast/enp95-environmental-impact-on-early-female-puberty Wed, 4 Dec 2024 00:00:00 EST There are plenty of studies showing that chemicals found in the environment can directly impact human health. Some new research finds that certain environmental compounds may trigger early female puberty. Joining host Aaron Lohr to talk about that research is Natalie Shaw, MD, a Lasker clinical research scholar and principal investigator of the pediatric neuroendocrinology group in the Clinical Research Branch of the National Institute of Environmental Health Sciences. Dr. Shaw and colleagues authored an article recently published in the journal Endocrinology titled, “Identification of Environmental Compounds That May Trigger Early Female Puberty by Activating Human GnRHR and KISS1R.” Show notes are available at https://www.endocrine.org/podcast/enp95-environmental-impact-on-early-female-puberty — for helpful links or to hear more podcast episodes, visit https://www.endocrine.org/podcast https://www.endocrine.org/-/media/8fb68cc0c4e64f5698ddd75b602f765c.m4a 9:07 There are plenty of studies showing that chemicals found in the environment can directly impact human health. Some new research finds that certain environmental compounds may trigger early female puberty. Joining host Aaron Lohr to talk about that research is Natalie Shaw, MD, a Lasker clinical research scholar and principal investigator of the pediatric neuroendocrinology group in the Clinical Research Branch of the National Institute of Environmental Health Sciences. Dr. Shaw and colleagues authored an article recently published in the journal Endocrinology titled, “Identification of Environmental Compounds That May Trigger Early Female Puberty by Activating Human GnRHR and KISS1R.” Show notes are available at https://www.endocrine.org/podcast/enp95-environmental-impact-on-early-female-puberty — for helpful links or to hear more podcast episodes, visit https://www.endocrine.org/podcast 2024 endocrine, endocrinology, edc, endocrine disrupting chemicals, GnRHR, KISS1R, female, reproductive, early puberty, environment, qHTS no https://www.endocrine.org/podcast/enp96-automated-insulin-delivery-systems Wed, 18 Dec 2024 00:00:00 EST There is a lot of interest in automated insulin delivery systems, and they were covered in depth at the Endocrine Society’s Type 1 Diabetes Fellows Series, held earlier this year. Joining host Aaron Lohr to talk about these delivery systems is Grazia Aleppo, MD, a professor of medicine at Northwestern University and a presenter at the T1D Fellows Series. Show notes are available at https://www.endocrine.org/podcast/enp96-automated-insulin-delivery-systems — for helpful links or to hear more podcast episodes, visit https://www.endocrine.org/podcast https://www.endocrine.org/-/media/8136d425394d44bfade19c5241c34406.m4a 19:13 There is a lot of interest in automated insulin delivery systems, and they were covered in depth at the Endocrine Society’s Type 1 Diabetes Fellows Series, held earlier this year. Joining host Aaron Lohr to talk about these delivery systems is Grazia Aleppo, MD, a professor of medicine at Northwestern University and a presenter at the T1D Fellows Series. Show notes are available at https://www.endocrine.org/podcast/enp96-automated-insulin-delivery-systems — for helpful links or to hear more podcast episodes, visit https://www.endocrine.org/podcast 2024 endocrine, endocrinology, insulin, diabetes, type 1 diabetes, t1d, t1dm, automated insulin delivery systems, insulin, delivery no https://www.endocrine.org/podcast/enp97-childhood-obesity-treatment Wed, 12 Feb 2025 00:00:00 EST What treatment options are available for children and adolescents with obesity? Host Aaron Lohr takes on this topic with Susan J. Woolford, MD, associate professor in the Child Health Evaluation and Research Center at the University of Michigan, and Sarah Giger, MD, a clinical fellow at Cincinnati’s Children’s Hospital. Both took part in the Endocrine Society’s recent obesity fellows conference. This episode is supported by an educational grant from Lilly and Novo Nordisk. Also, this episode is available to listen for 0.5 CME credits, but you must follow the link to the show notes and read the instructions in order to earn those points. Show notes are available at https://www.endocrine.org/podcast/enp97-childhood-obesity-treatment — for helpful links or to hear more podcast episodes, visit https://www.endocrine.org/podcast https://www.endocrine.org/-/media/decd375fd5944389b543d0942683d6a6.m4a 26:04 What treatment options are available for children and adolescents with obesity? Host Aaron Lohr takes on this topic with Susan J. Woolford, MD, associate professor in the Child Health Evaluation and Research Center at the University of Michigan, and Sarah Giger, MD, a clinical fellow at Cincinnati’s Children’s Hospital. Both took part in the Endocrine Society’s recent obesity fellows conference. This episode is supported by an educational grant from Lilly and Novo Nordisk. Also, this episode is available to listen for 0.5 CME credits, but you must follow the link to the show notes and read the instructions in order to earn those points. Show notes are available at https://www.endocrine.org/podcast/enp97-childhood-obesity-treatment — for helpful links or to hear more podcast episodes, visit https://www.endocrine.org/podcast 2025 endocrine, endocrinology, obesity, pediatrics, pediatric, pediatric obesity, childhood obesity, children, adolescents, diabetes, type 1 diabetes, t1d, t1dm, insulin no https://www.endocrine.org/podcast/enp98-opioids-and-the-endocrine-system Wed, 19 Mar 2025 05:00:00 EDT Increased prescription of opioid medications like oxycodone and hydrocodone has led to widespread misuse of both prescription and non-prescription opioids. But did you know that opioid misuse can significantly impact the endocrine system? The Endocrine Society recently published a scientific statement titled, “Exogenous Opioids and the Human Endocrine System: An Endocrine Society Scientific Statement.” The statement reviews data on the use and misuse of opioids and discusses recent research on the endocrine-related implications of opioid use. Host Aaron Lohr talks to one of the statement’s authors, Niki Karavitaki, MD, PhD, a professor from the Institute of Metabolism and Systems Research at the University of Birmingham in the United Kingdom. Show notes are available at https://www.endocrine.org/podcast/enp98-opioids-and-the-endocrine-system — for helpful links or to hear more podcast episodes, visit https://www.endocrine.org/podcast https://www.endocrine.org/-/media/480a572bc4004807bb90bba3123cb38c.m4a 17:13 Increased prescription of opioid medications like oxycodone and hydrocodone has led to widespread misuse of both prescription and non-prescription opioids. But did you know that opioid misuse can significantly impact the endocrine system? The Endocrine Society recently published a scientific statement titled, “Exogenous Opioids and the Human Endocrine System: An Endocrine Society Scientific Statement.” The statement reviews data on the use and misuse of opioids and discusses recent research on the endocrine-related implications of opioid use. Host Aaron Lohr talks to one of the statement’s authors, Niki Karavitaki, MD, PhD, a professor from the Institute of Metabolism and Systems Research at the University of Birmingham in the United Kingdom. Show notes are available at https://www.endocrine.org/podcast/enp98-opioids-and-the-endocrine-system — for helpful links or to hear more podcast episodes, visit https://www.endocrine.org/podcast 2025 endocrine, endocrinology, opioids, opiates, hypothalamic-pituitary, hypopituitarism, hypogonadism, bones, oxycodone, hydrocodone no https://www.endocrine.org/podcast/enp99 Wed, 9 Jul 2025 00:00:00 EDT Recently the Endocrine Society’s Bone and Mineral Special Interest Group discussed the importance of fracture liaison services and how they contribute to an improved quality of life for patients and cost saving for the facility. An important part of the discussion revolved around a recent perspective published in The New England Journal of Medicine titled, “Coordinating Multidisciplinary Care — Improving Outcomes after Fragility Fractures.” The article notes that despite the benefits of fracture liaison services, the lack of reimbursement for those services in the United States is a significant financial barrier, rendering the service underutilized. The article further states that the global burden of hip fractures is expected to double over the next few decades. Are we looking at an impending crisis? What role should fracture liaison services play in reducing treatment gaps and improving post-fracture care? Host Aaron Lohr talks with the three authors of that New England Journal of Medicine perspective: Nicola Napoli, MD, PhD, associate professor of endocrinology and metabolism at Campus Bio-Medico University of Rome, Italy; Peter Ebeling, AO, professor medicine at Monash University in Melbourne, Vic., Australia; and Douglas P. Kiel, MD, professor of medicine at Marcus Institute for Aging Research at Hebrew Senior Life. Show notes are available at https://www.endocrine.org/podcast/enp99 — for helpful links or to hear more podcast episodes, visit https://www.endocrine.org/podcast https://www.endocrine.org/-/media/a66a83e538c4419da2ddbfdbb4a0ad68.m4a 19:17 Recently the Endocrine Society’s Bone and Mineral Special Interest Group discussed the importance of fracture liaison services and how they contribute to an improved quality of life for patients and cost saving for the facility. An important part of the discussion revolved around a recent perspective published in The New England Journal of Medicine titled, “Coordinating Multidisciplinary Care — Improving Outcomes after Fragility Fractures.” The article notes that despite the benefits of fracture liaison services, the lack of reimbursement for those services in the United States is a significant financial barrier, rendering the service underutilized. The article further states that the global burden of hip fractures is expected to double over the next few decades. Are we looking at an impending crisis? What role should fracture liaison services play in reducing treatment gaps and improving post-fracture care? Host Aaron Lohr talks with the three authors of that New England Journal of Medicine perspective: Nicola Napoli, MD, PhD, associate professor of endocrinology and metabolism at Campus Bio-Medico University of Rome, Italy; Peter Ebeling, AO, professor medicine at Monash University in Melbourne, Vic., Australia; and Douglas P. Kiel, MD, professor of medicine at Marcus Institute for Aging Research at Hebrew Senior Life. Show notes are available at https://www.endocrine.org/podcast/enp99 — for helpful links or to hear more podcast episodes, visit https://www.endocrine.org/podcast 2025 endocrine, endocrinology, aging, fracture, fractures, hip, bone, mineral, fracture liaison services, osteoporosis no https://www.endocrine.org/podcast/enp100 Wed, 13 Aug 2025 00:00:00 EDT After seven years, we have reached our 100th episode! For this, we talk about growth hormone deficiency, about causes, prevalence, why some types may become permanent, available treatments, and the importance of adherence to treatment plans. Host Aaron Lohr talks with Sandro Loche, MD, of Bambino Gesù Children’s Hospital in Rome, Italy. Recently, Dr. Loche and colleagues presented research at ENDO 2025 in San Francisco titled, “Adherence to GH Treatment in the Transition Age: A Prospective Study.” Show notes are available at https://www.endocrine.org/podcast/enp100 — for helpful links or to hear more podcast episodes, visit https://www.endocrine.org/podcast https://www.endocrine.org/-/media/265f2aeed45f4030ba933228b547b1b6.m4a 16:35 After seven years, we have reached our 100th episode! For this, we talk about growth hormone deficiency, about causes, prevalence, why some types may become permanent, available treatments, and the importance of adherence to treatment plans. Host Aaron Lohr talks with Sandro Loche, MD, of Bambino Gesù Children’s Hospital in Rome, Italy. Recently, Dr. Loche and colleagues presented research at ENDO 2025 in San Francisco titled, “Adherence to GH Treatment in the Transition Age: A Prospective Study.” Show notes are available at https://www.endocrine.org/podcast/enp100 — for helpful links or to hear more podcast episodes, visit https://www.endocrine.org/podcast 2025 endocrine, endocrinology, growth, hormone, deficiency, growth hormone deficiency, gh, ghd no https://www.endocrine.org/podcast/enp101 Wed, 3 Sep 2025 05:30:00 EDT Papillary thyroid cancer is the most common type of thyroid cancer, and yet in rare cases, this cancer may originate in locations other than the thyroid glands. In this episode, host Aaron Lohr talks about causes, prevalence, and treatment for papillary thyroid cancer and the rare phenomenon known as ectopic papillary thyroid cancer with Nikita Dhir, MD, of University of Texas Health Science Center at Houston. Dr. Dhir and colleagues presented research at ENDO 2025 in San Francisco titled, “Where Is the Primary Papillary Thyroid Cancer?” Show notes are available at https://www.endocrine.org/podcast/enp101 — for helpful links or to hear more podcast episodes, visit https://www.endocrine.org/podcast https://www.endocrine.org/-/media/f0473b75a05e43e6858bb3fbd1984ba5.m4a 16:35 Papillary thyroid cancer is the most common type of thyroid cancer, and yet in rare cases, this cancer may originate in locations other than the thyroid glands. In this episode, host Aaron Lohr talks about causes, prevalence, and treatment for papillary thyroid cancer and the rare phenomenon known as ectopic papillary thyroid cancer with Nikita Dhir, MD, of University of Texas Health Science Center at Houston. Dr. Dhir and colleagues presented research at ENDO 2025 in San Francisco titled, “Where Is the Primary Papillary Thyroid Cancer?” Show notes are available at https://www.endocrine.org/podcast/enp101 — for helpful links or to hear more podcast episodes, visit https://www.endocrine.org/podcast 2025 endocrine, endocrinology, papillary thyroid cancer, papillary, thyroid, cancer no https://www.endocrine.org/podcast/enp102 Wed, 17 Sep 2025 08:00:00 EDT In this episode, we cover type 1 diabetes and especially insulin delivery systems. Host Aaron Lohr talks with Grazia Aleppo, MD, from Northwestern University’s Feinberg School of Medicine and Diana Isaacs, PharmD, director of education and training in diabetes technology at the Cleveland Clinic. This episode is certified for up to 0.5 AMA PRA Category 1 credits and ABIM MOC points. However, claiming those points requires taking a pre-episode test. Then you must listen to the episode on the Endocrine Society’s Center for Learning website, followed by a post-episode test and evaluation. Please check the show notes for the appropriate link. This episode is supported by educational grants by MannKind Corp. and Insulet Corp. Show notes are available at https://www.endocrine.org/podcast/enp102 — for helpful links or to hear more podcast episodes, visit https://www.endocrine.org/podcast https://www.endocrine.org/-/media/7bd0e6234da84497a68140ebf13d1c1f.m4a 31:56 In this episode, we cover type 1 diabetes and especially insulin delivery systems. Host Aaron Lohr talks with Grazia Aleppo, MD, from Northwestern University’s Feinberg School of Medicine and Diana Isaacs, PharmD, director of education and training in diabetes technology at the Cleveland Clinic. This episode is certified for up to 0.5 AMA PRA Category 1 credits and ABIM MOC points. However, claiming those points requires taking a pre-episode test. Then you must listen to the episode on the Endocrine Society’s Center for Learning website, followed by a post-episode test and evaluation. Please check the show notes for the appropriate link. This episode is supported by educational grants by MannKind Corp. and Insulet Corp. Show notes are available at https://www.endocrine.org/podcast/enp102 — for helpful links or to hear more podcast episodes, visit https://www.endocrine.org/podcast 2025 endocrine, endocrinology, diabetes, t1d, type 1 diabetes, insulin, insulin delivery systems, delivery, insulin delivery, insulin pump no https://www.endocrine.org/podcast/enp103 Wed, 1 Oct 2025 00:00:00 EDT Recently the Endocrine Society held its 12th annual Type 1 Diabetes Fellows Series program, which combines comprehensive education on type 1 diabetes with career development opportunities to build knowledge, practical skills, and a lasting network of colleagues. For this episode, host Aaron Lohr talks with Desmond Schatz, MD, medical director of the Diabetes Institute and director of the Clinical Research Center at the University of Florida. Dr. Schatz gave a talk at the fellows series program titled, “Immunotherapies for Type 1 Diabetes: Need for Early Detection and Screening.” This year’s fellows series program and this episode were made possible by the support of Abbott Diabetes Care, CeQur Corp., Dexcom Inc., Insulet Corp., Breakthrough T1D (formerly the Juvenile Diabetes Research Foundation), Lilly USA, Mankind Pharma Limited, Medtronic Inc., Novo Nordisk Inc., and Vertex Pharmaceuticals Inc. Show notes are available at https://www.endocrine.org/podcast/enp103 — for helpful links or to hear more podcast episodes, visit https://www.endocrine.org/podcast https://www.endocrine.org/-/media/83ff4310132344aa8654038201cb9f85.m4a 23:20 Recently the Endocrine Society held its 12th annual Type 1 Diabetes Fellows Series program, which combines comprehensive education on type 1 diabetes with career development opportunities to build knowledge, practical skills, and a lasting network of colleagues. For this episode, host Aaron Lohr talks with Desmond Schatz, MD, medical director of the Diabetes Institute and director of the Clinical Research Center at the University of Florida. Dr. Schatz gave a talk at the fellows series program titled, “Immunotherapies for Type 1 Diabetes: Need for Early Detection and Screening.” This year’s fellows series program and this episode were made possible by the support of Abbott Diabetes Care, CeQur Corp., Dexcom Inc., Insulet Corp., Breakthrough T1D (formerly the Juvenile Diabetes Research Foundation), Lilly USA, Mankind Pharma Limited, Medtronic Inc., Novo Nordisk Inc., and Vertex Pharmaceuticals Inc. Show notes are available at https://www.endocrine.org/podcast/enp103 — for helpful links or to hear more podcast episodes, visit https://www.endocrine.org/podcast 2025 endocrine, endocrinology, diabetes, t1d, type 1 diabetes, insulin, immunotherapy, immunotherapies, early detection screening no https://www.endocrine.org/podcast/enp104 Wed, 15 Oct 2025 05:30:00 EDT In the United States, the Food and Drug Administration doesn’t regulate supplements for safety and efficacy, so manufacturers don’t have to disclose their ingredients. We can’t always know for certain what’s in supplements we buy over the counter. Host Aaron Lohr talks with Meghana Pattipati, MD, an endocrine specialist at Ochsner Lafayette General Medical Center in Louisiana. Dr. Pattipati presented a study at ENDO 2025 in San Francisco titled, “Beware of the Hidden Ingredients and Supplement Use in Your Patients With Elevated Testosterone.” The presentation describes a case where a patient unknowingly ingested an ingredient that had a significant endocrine impact. Show notes are available at https://www.endocrine.org/podcast/enp104 — for helpful links or to hear more podcast episodes, visit https://www.endocrine.org/podcast https://www.endocrine.org/-/media/4c9bf06be0774ef58fcb76905c704708.m4a 10:47 In the United States, the Food and Drug Administration doesn’t regulate supplements for safety and efficacy, so manufacturers don’t have to disclose their ingredients. We can’t always know for certain what’s in supplements we buy over the counter. Host Aaron Lohr talks with Meghana Pattipati, MD, an endocrine specialist at Ochsner Lafayette General Medical Center in Louisiana. Dr. Pattipati presented a study at ENDO 2025 in San Francisco titled, “Beware of the Hidden Ingredients and Supplement Use in Your Patients With Elevated Testosterone.” The presentation describes a case where a patient unknowingly ingested an ingredient that had a significant endocrine impact. Show notes are available at https://www.endocrine.org/podcast/enp104 — for helpful links or to hear more podcast episodes, visit https://www.endocrine.org/podcast 2025 endocrine, endocrinology, nutrition, supplements, vitamins, testosterone, male reproductive endocrinology, male reproduction, endocrine disrupting chemicals, edc no https://www.endocrine.org/podcast/enp105 Wed, 29 Oct 2025 05:15:00 EDT In this episode, we take a closer look at tirzepatide, a type 2 diabetes medication also used to help with weight loss. Postmenopause weight gain can be a normal part of aging, and there are some questions about whether medications like tirzepatide could be useful and safe for postmenopausal women. Host Aaron Lohr talks with Maria Daniela Hurtado Andrade, MD, PhD, assistant professor of medicine at Mayo Clinic Florida, and Regina Castaneda, MD, a research fellow at Mayo Clinic College of Medicine & Science. They presented an abstract at ENDO 2025 titled, “One-Year Real-World Weight Loss Outcomes with Tirzepatide in Postmenopausal Women With and Without Hormone Therapy.” Show notes are available at https://www.endocrine.org/podcast/enp105 — for helpful links or to hear more podcast episodes, visit https://www.endocrine.org/podcast https://www.endocrine.org/-/media/96f55ad3994f42ba85329a583227f9b0.m4a 18:36 In this episode, we take a closer look at tirzepatide, a type 2 diabetes medication also used to help with weight loss. Postmenopause weight gain can be a normal part of aging, and there are some questions about whether medications like tirzepatide could be useful and safe for postmenopausal women. Host Aaron Lohr talks with Maria Daniela Hurtado Andrade, MD, PhD, assistant professor of medicine at Mayo Clinic Florida, and Regina Castaneda, MD, a research fellow at Mayo Clinic College of Medicine & Science. They presented an abstract at ENDO 2025 titled, “One-Year Real-World Weight Loss Outcomes with Tirzepatide in Postmenopausal Women With and Without Hormone Therapy.” Show notes are available at https://www.endocrine.org/podcast/enp105 — for helpful links or to hear more podcast episodes, visit https://www.endocrine.org/podcast 2025 endocrine, endocrinology, womens reproductive endocrinology, obesity, tirzepatide, menopause, postmenopause, mounjaro no https://www.endocrine.org/podcast/enp106 Wed, 12 Nov 2025 05:25:00 EST Bariatric surgery is a procedure used to manage obesity and obesity-related conditions. While studies have shown that bariatric surgery leads to significant weight loss, are there cases where it may be important to consider reversing the procedure? What would such cases look like? How effectively can bariatric surgery be reversed? To help explore those questions, host Aaron Lohr talks with Katherine Hazen, MD, a second-year endocrine fellow at the University of Rochester Medical Center. She and colleagues presented an abstract at ENDO 2025 titled, “Going Backwards as a Means of Moving Forward: Severe Hypoglycemia After Bariatric Surgery.” Show notes are available at https://www.endocrine.org/podcast/enp106 — for helpful links or to hear more podcast episodes, visit https://www.endocrine.org/podcast https://www.endocrine.org/-/media/521170749dc74a07abe0b7d36ff8488b.m4a 12:28 Bariatric surgery is a procedure used to manage obesity and obesity-related conditions. While studies have shown that bariatric surgery leads to significant weight loss, are there cases where it may be important to consider reversing the procedure? What would such cases look like? How effectively can bariatric surgery be reversed? To help explore those questions, host Aaron Lohr talks with Katherine Hazen, MD, a second-year endocrine fellow at the University of Rochester Medical Center. She and colleagues presented an abstract at ENDO 2025 titled, “Going Backwards as a Means of Moving Forward: Severe Hypoglycemia After Bariatric Surgery.” Show notes are available at https://www.endocrine.org/podcast/enp106 — for helpful links or to hear more podcast episodes, visit https://www.endocrine.org/podcast 2025 endocrine, endocrinology, obesity, adipose, hypoglycemia, bariatric, bariatric surgery, RYGB, gastric bypass, Roux-en-Y gastric bypass, VPS13B, postprandial, glucose, insulin, diabetes no https://www.endocrine.org/podcast/enp107 Wed, 3 Dec 2025 04:30:00 EST Technically known as glucagon-like peptide-1 receptor agonists, or GLP-1, these drugs have been around for years for treating diabetes. Now it seems most people think of GLP-1 drugs as medications to lose weight, and these medications are so popular that for a time, supply could not meet demand, leaving many to seek compounded GLP-1 medications, which were more accessible and affordable. However, compounded medications are not FDA-approved, and there are questions regarding their safety and efficacy. What do doctors and patients need to know when considering using compounded obesity medications? To help answer this, host Aaron Lohr talks with Michael Weintraub, MD, an endocrinologist at NYU Langone Division of Endocrinology. Dr. Weintraub serves on the exam writing committee for the American Board of Obesity Medicine. Support for this episode was provided by Lilly. Show notes are available at https://www.endocrine.org/podcast/enp107 — for helpful links or to hear more podcast episodes, visit https://www.endocrine.org/podcast https://www.endocrine.org/-/media/90a30c034942425ebcdb4b5f6aa69ab2.m4a 11:49 Technically known as glucagon-like peptide-1 receptor agonists, or GLP-1, these drugs have been around for years for treating diabetes. Now it seems most people think of GLP-1 drugs as medications to lose weight, and these medications are so popular that for a time, supply could not meet demand, leaving many to seek compounded GLP-1 medications, which were more accessible and affordable. However, compounded medications are not FDA-approved, and there are questions regarding their safety and efficacy. What do doctors and patients need to know when considering using compounded obesity medications? To help answer this, host Aaron Lohr talks with Michael Weintraub, MD, an endocrinologist at NYU Langone Division of Endocrinology. Dr. Weintraub serves on the exam writing committee for the American Board of Obesity Medicine. Support for this episode was provided by Lilly. Show notes are available at https://www.endocrine.org/podcast/enp107 — for helpful links or to hear more podcast episodes, visit https://www.endocrine.org/podcast 2025 endocrine, endocrinology, obesity, adipose, glp1, glp-1, compound, compounded, compounded medication, compounded medicine, glucagon like peptide 1 receptor agonists no https://www.endocrine.org/podcast/enp108 Wed, 17 Dec 2025 05:00:00 EST In the last five years, the field of artificial intelligence and robotics has taken off and has become a part of our everyday life, and it continues to grow and evolve. How are AI and robotics shaping the field of medicine? How is it improving the lives of doctors and patients? We used to ask, “What is the role of AI in medicine?” Are we getting closer to a time where we’ll be asking what the role is of humans? To help us answer these questions, host Aaron Lohr talks with Hassan M. Heshmati, MD. Dr. Heshmati has been a physician for 49 years and an endocrinologist for 45 years, with experience in clinical research and academia and in the pharmaceutical biotech industry. He founded Endocrinology Metabolism Consulting, based in Anthem, Ariz., and presented an abstract at ENDO 2025 titled, “Update on the Use of Robotic Surgery and Artificial Intelligence for Adrenal Tumors.” Show notes are available at https://www.endocrine.org/podcast/enp108 — for helpful links or to hear more podcast episodes, visit https://www.endocrine.org/podcast https://www.endocrine.org/-/media/78dde4c1067e49859d527a9472b9a485.m4a 10:28 In the last five years, the field of artificial intelligence and robotics has taken off and has become a part of our everyday life, and it continues to grow and evolve. How are AI and robotics shaping the field of medicine? How is it improving the lives of doctors and patients? We used to ask, “What is the role of AI in medicine?” Are we getting closer to a time where we’ll be asking what the role is of humans? To help us answer these questions, host Aaron Lohr talks with Hassan M. Heshmati, MD. Dr. Heshmati has been a physician for 49 years and an endocrinologist for 45 years, with experience in clinical research and academia and in the pharmaceutical biotech industry. He founded Endocrinology Metabolism Consulting, based in Anthem, Ariz., and presented an abstract at ENDO 2025 titled, “Update on the Use of Robotic Surgery and Artificial Intelligence for Adrenal Tumors.” Show notes are available at https://www.endocrine.org/podcast/enp109 — for helpful links or to hear more podcast episodes, visit https://www.endocrine.org/podcast 2025 endocrine, endocrinology, obesity, artificial intelligence, ai, robotics, surgery, adrenal no https://www.endocrine.org/podcast/enp109 Wed, 7 Jan 2026 04:00:00 EST In recent years, we have seen tremendous growth not just in the popularity of anti-obesity medications, but also in the medications themselves, how effective they are, how many there are. What exactly has changed during this rapid evolution? How safe and effective are these medications today? What challenges still exist in using them? To help answer these questions, host Aaron Lohr speaks with Gitanjali Srivastava, MD, professor of medicine, medical director of Vanderbilt Obesity Medicine, and founding program director of the Obesity Medicine Fellowship at Vanderbilt University Medical Center. Dr. Srivastava presented at the Endocrine Society’s Obesity Fellows Conference in September 2025. The title of her presentation was “Pharmacological Approaches to Treating and Understanding Complicated Obesity.” Listening to this episode can earn you 0.5 ABIM MOC points and 0.5 AMA PRA Category 1 credits. If you are interested in those points and credits, you will need to take a pre-test on the Endocrine Society Center for Learning before listening to this episode. You can find a link in this episode’s show notes. After that pre-test, listen to this episode in the Center for Learning, then take the post-test. This episode is made possible by educational grants from Lilly and Novo Nordisk. Show notes are available at https://www.endocrine.org/podcast/enp109 — for helpful links or to hear more podcast episodes, visit https://www.endocrine.org/podcast https://www.endocrine.org/-/media/0189a5902bbb4c058a027008089ae1a9.m4a 13:15 In recent years, we have seen tremendous growth not just in the popularity of anti-obesity medications, but also in the medications themselves, how effective they are, how many there are. What exactly has changed during this rapid evolution? How safe and effective are these medications today? What challenges still exist in using them? To help answer these questions, host Aaron Lohr speaks with Gitanjali Srivastava, MD, professor of medicine, medical director of Vanderbilt Obesity Medicine, and founding program director of the Obesity Medicine Fellowship at Vanderbilt University Medical Center. Dr. Srivastava presented at the Endocrine Society’s Obesity Fellows Conference in September 2025. The title of her presentation was “Pharmacological Approaches to Treating and Understanding Complicated Obesity.” Listening to this episode can earn you 0.5 ABIM MOC points and 0.5 AMA PRA Category 1 credits. If you are interested in those points and credits, you will need to take a pre-test on the Endocrine Society Center for Learning before listening to this episode. You can find a link in this episode’s show notes. After that pre-test, listen to this episode in the Center for Learning, then take the post-test. This episode is made possible by educational grants from Lilly and Novo Nordisk. Show notes are available at https://www.endocrine.org/podcast/enp108 — for helpful links or to hear more podcast episodes, visit https://www.endocrine.org/podcast 2026 endocrine, endocrinology, obesity, adipose, glp1, medications, glucagon like peptide 1 receptor agonists no https://www.endocrine.org/podcast/enp110 Wed, 21 Jan 2026 06:00:00 EST For some people, diabetes can be very hard to control, even with the standard glucose-lowering therapies. Several studies have demonstrated that endogenous hypercortisolism is prevalent among these individuals. What’s the relationship between type 2 diabetes and hypercortisolism, and what do health care providers need to know about that relationship? To help answer those questions, host Aaron Lohr talks with two guests. Vivian A. Fonseca, MD, is a professor of medicine, assistant dean for clinical research, the Tullis-Tulane Alumni Chair in Diabetes, and chief of the section of endocrinology at Tulane University Medical Center in New Orleans. James W. Findling, MD, is a professor of medicine and surgery at the Medical College of Wisconsin. Drs. Fonseca and Findling are authors of an article published in the journal Diabetes Care looking at the CATALYST study: “Inadequately Controlled Type 2 Diabetes and Hypercortisolism: Improved Glycemia With Mifepristone Treatment.” This episode is made possible by support from Corcept Therapeutics Inc. Show notes are available at https://www.endocrine.org/podcast/enp110 — for helpful links or to hear more podcast episodes, visit https://www.endocrine.org/podcast https://www.endocrine.org/-/media/137d45405a104ddeb936b68ec2410a2d.m4a 20:03 For some people, diabetes can be very hard to control, even with the standard glucose-lowering therapies. Several studies have demonstrated that endogenous hypercortisolism is prevalent among these individuals. What’s the relationship between type 2 diabetes and hypercortisolism, and what do health care providers need to know about that relationship? To help answer those questions, host Aaron Lohr talks with two guests. Vivian A. Fonseca, MD, is a professor of medicine, assistant dean for clinical research, the Tullis-Tulane Alumni Chair in Diabetes, and chief of the section of endocrinology at Tulane University Medical Center in New Orleans. James W. Findling, MD, is a professor of medicine and surgery at the Medical College of Wisconsin. Drs. Fonseca and Findling are authors of an article published in the journal Diabetes Care looking at the CATALYST study: “Inadequately Controlled Type 2 Diabetes and Hypercortisolism: Improved Glycemia With Mifepristone Treatment.” This episode is made possible by support from Corcept Therapeutics Inc. Show notes are available at https://www.endocrine.org/podcast/enp110 — for helpful links or to hear more podcast episodes, visit https://www.endocrine.org/podcast 2026 endocrine, endocrinology, diabetes, t2d, type 2 diabetes, hypercortisolism, mifepristone, catalyst, catalyst trial no